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Abstract
The molecular responses to radiation exposure have been an avidly pursued
research topic for many years now. Most of this effort has been focused on large doses of
radiation, such as those experienced during a nuclear explosion or cancer treatment. Of
equal importance though, are the effects of low doses of radiation, which have received
much less attention. This study attempts to analyze the effects of low-dose radiation
exposure on different inbred mice strains, each of which represents a unique genetic
constitution. The genetic background was found to have a dramatic effect on the
variability of gene expression of the irradiated mice, with anywhere from 950 to 6900
genes significantly variable. This effect was found to be more extreme in some strains
compared to others, as well as being much more prominent in skin tissue than spleen
tissue. Additionally, 200 to 3500 of the genes found to have variable expression were
only variable in one of the inbred strains, which again show that the genetic background
has an impact on different responses to radiation exposure. It was also found that
performing microarray hybridizations using RNA that comes from multiple animals
dramatically increases the variability of gene expression, when compared to RNA that
comes from a single animal.
Pathway analysis and network construction methods have become a popular topic
of interest in the bioinformatics community, which has been a result of the large volumes
of data being produced through high-throughput genomics experiments. One popular
method for building such pathways are through the use of Bayesian Networks. Many
questions remain unresolved in their application though, such as how many experiments
are required before an accurate model can be produced, and how accurate is that model.
Based upon the simulations run, a minimum of 300 data points is required to obtain a
graph that resembles the true structure, while more than 300 data points continues to
improve the accuracy. The same number of data points also consistently produced the
highest scoring graph, and allowed for the identification of modules within the graphs.
The accuracy of this decreased though as the size of the graphs increased. Therefore, in
consideration of applying such a method to the biological domain, a minimum of 300
experiments should be included before attempting to build a small network.
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Chapter 1
Introduction & background
I. Introduction
The study of the effects of ionizing radiation is an important topic in relation to
human health. Everyone is exposed to a low level of background radiation. Natural
sources of radiation come from a variety of locations, such as exposure to radon, cosmic
radiation and ingestion [1]. In addition to this, many medical procedures such as CT
scans, cancer treatments, consumer products and medical X-rays expose many people to
an increased dose of radiation. There are also potential catastrophic events, such as
atomic bombs, terrorist "dirty bombs" or nuclear accidents, which could produce largescale radiation exposure to populations of entire cities. Given the wide variety of sources
of radiation, both natural and man-made, it is important to understand the effects
radiation exposure has on living cells and the human body. Much of the research done to
this point has focused on the effects of large doses of radiation, leaving the effects of
smaller doses of radiation fairly unknown. In addition, as for most diseases or
environmental exposures, genetic background significantly influences the response to
radiation, including exposures to low doses. Therefore, the study presented here focuses
on the effects of 10 cGy of radiation, which is considered a low-dose by the Department
of Energy. The goal of the study is 2-fold: 1.) to identify the genes that respond to low
dose radiation in vivo as a means to identify pathways that are activated/repressed in the
cell; and 2.) to determine the extent to which genetic background alters the radiation
response. The latter goal is addressed by using inbred strains of laboratory mice to model
the genetic variability seen in human populations.
In the field of bioinformatics, much attention has been given recently to the
construction of gene regulatory networks, and methods for the high throughput
elucidation of genetic pathways. In light of this, the ultimate goal in the study of the
effects of radiation would be to know which pathways and regulatory networks are
affected by the radiation exposure and exactly which genes are changing and in what
ways they change. The methods being used to produce such networks are not entirely
accurate or reliable, nor do they measure all the factors and events that one might wish to
know in experimentally determining these regulatory networks. Thus, achieving a goal
of completely determining such networks remains elusive. However, methods for
constructing and modeling networks are steadily improving. There is a need for assess
the current methods of elucidating networks, in part to provide feedback on the future
needs for better experimental data and better network modeling methods. Therefore, a
second goal of this study is to implement a common network construction algorithm and
determine its effectiveness if applied to the gene expression data used in this study.
This thesis is organized as follows: the remainder of Chapter 1 contains
background information on different topics relevant to Chapters 2 and 3. It is grouped
together by topic, each of which appears in the order they are encountered in the
subsequent chapters. Chapter 2 discusses the analysis of the low-dose data, and the
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variability of gene expression both between and within the different inbred mouse
strains. Chapter 3 is an investigation into pathway construction using Bayesian
Networks, and discusses the potential for the elucidation of modules of interacting genes
from high throughput data.
II. Low-Dose Radiation
Ionizing radiation is radiation that has enough energy to displace electrons from
molecules [1]. Those displaced electrons can subsequently cause significant damage to
live cells. Differing amounts of ionizing radiation have disparate biological effects. In
general, radiation exposure is separated into two different groups: low- and high-doses.
Low-dose radiation is generally defined as being anywhere in the range of zero to 100
mGy of radiation [1]. In the United States, the average annual amount of background
radiation exposure is 3.0 mGy [1]. On average, one in one hundred people would be
expected to develop cancer due to a lifetime of exposure to low-doses of radiation, which
40 of those 100 would be expected to develop cancer from leukemia or some other cause
[1]. Despite the fact that the biological effect of radiation exposure is a widely studied
topic, there is little information known about the effects of exposure to low doses of
radiation [2]. In general, knowledge of the effects of low doses of radiation is
extrapolated from knowledge of the effects of high doses of radiation, such as from
Japanese atomic-bomb survivors [3]. While this may be acceptable under some
circumstances, there have been shown to be effects of low-dose radiation exposure that
differ from those exhibited resulting from high dose exposure, and vice versa [2].
Several models of the effects of low dose radiation exist. The most popular and
controversial is the linear nonthreshold model, which proposes that low-dose radiation is
just as harmful per gray as high-dose radiation [3]. Because of the complex biological
effects of radiation, data exists that supports other models as well. One such model is a
threshold model that proposes that low-dose radiation is harmless below a certain level.
For the most part, this model is supported by the epidemiological data mainly of the life
span of atomic bomb survivors, which seems to indicate in some cases a linearity
between dose and risk at low doses [3]. Another popular model is the adaptive response
model, which states certain amounts of low-dose radiation may even be beneficial [2-4].
Typically, the adaptive response is induced with 1-100 mGy of γ-rays, which is 10010,000 times larger than natural background. A fourth model is the bystander effect
model, which proposes that low-dose radiation may be even more damaging than that
predicted by the linear nonthreshold model. It has been suggested that irradiated cells
may signal their distress to each other, possibly through direct cell-to-cell interaction or
by molecules secreted into the medium [3].
It has been found though, that low-dose radiation suppresses the molecular
responses which prohibit the genotoxic effect of subsequent irradiation [5]. This is
known as the radioadaptive response, and although the mechanism responsible for this is
not yet known it has been suggested that suppression of p53-mediated apoptosis [6] and
the responsiveness of protein kinase C are involved [7]. In humans the issue of radiation
response is of particular importance, since many health risks have been associated with
low doses of radiation. Such risks include neoplastic diseases, somatic mutations that
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may contribute to other illnesses (including birth defects and other problems) and
heritable mutations that may increase the risk of diseases in future generations [8, 9].
All amounts of irradiation are known to initiate a plethora of signal transduction
cascades responsible for maintaining cellular homeostasis and promoting interactions
with neighboring cells. This has been found to cause large-scale changes in gene
expression levels, with specific implications for DNA repair, cell cycle arrest, growth
control, and cell signaling [10]. The dose of radiation has been shown to have a
significant effect on the number of genes with modulated expression patterns, as well as
affecting genes with different functional classifications [11].
Because of the significant potential effects of radiation exposure noted above, and
the current lack of understanding of the biological mechanisms affected by low-dose
radiation exposure, this is an extremely important topic to pursue. While ideally the
effects on humans are the focal point of any such study, for obvious reasons this cannot
be done in a controlled study. Therefore, inbred mouse strains are an obvious alternative
model organism. There are more than 450 different inbred mouse strains that now exist
and are commonly used in laboratory experimentation [12]. A family tree of inbred
mouse strains appears in Figure 1.1, which represents 102 of the strains [13].
While the different inbred mouse strains represent genetically distinct populations,
multiple animals from the same inbred strain can be considered to have identical genetic
constitutions. It is widely known however, that there are many polymorphisms that exist
both within and between the strains, which could come into play when considering the
effects of low-dose radiation. It has been found that the mean number of polymorphisms
between strains is 608 ± 136 SD [13]. It has already been shown that different mice
strains have variable sensitivities to mutagens, such as ethyl nitrosurea (ENU). In
particular, BALB/c and C3H strains are particularly sensitive to this mutagen [12].
Because of the known genetic variation between strains, it stands to reason that
there would be variability in the levels of gene expression as well. This issue is of
particular interest to this study, as this will directly relate to inter-individual differences in
response to the low-dose radiation treatment being applied. While most authors focus
only on calculating differential expression between a treatment and control group, it is of
great interest to also assess the variability between genetically distinct individuals.
Therefore, not only the effects a low-dose radiation treatment, but also a baseline
measure of the variability of gene expression between inbred mice strains would be of
great value to the scientific community studying this topic.
The ultimate goal in studying the effects of radiation exposure is to understand the
affected pathways, and how the transcription of the involved genes is modified in
response to the treatment. While many methods have been developed to predict
pathways from gene expression data, this is still a subjective and imperfect process. Due
to the volumes of gene expression data being produced worldwide, pathway prediction
has become an increasingly popular topic in the bioinformatics community; however it is
fraught with complications and difficulties, as well as each method having well-known
drawbacks. Of particular interest to this study, is how the genes identified as being
highly variable and/or differentially expressed between the different mouse strains are
related in terms of affected pathways. To work towards this goal though, it is first
necessary to study the effectiveness and accuracy of network construction methods.
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Figure 1.1: Mouse family tree. There are 7 groups of mouse strains. Group
1: Bagg albino; Group 2: Swiss mice; Group 3: Japanese and New Zealand
inbred strains; Group 4: C57/58 strains; Group 5: Castle’s mice; Group 6:
C.C. Little’s DBA and related strains; Group 7: Wild-derived strains. Branch
lengths do not reflect evolutionary distances.
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III. Microarray Normalization
The normalization of microarray data is an important step in the data analysis
process. There are many sources of variation that exist in microarray experiments, which
can have dramatic effects on measured gene expression levels [14]. Normalization is the
process of removing technical sources of variation, so that the resulting data is
comparable across different arrays in the same experiment, and biological differences can
be more easily distinguished. There are many different ways that researchers have
approached the normalization process. The types and amount of normalization required
often depends upon the experimental design, and types of arrays used. Some of these
methods are covered here, although this is not a comprehensive survey of all possible
methods.
One of the earliest methods used for normalization was to have a set of
“housekeeping” genes on an array, to which all genes were normalized. It was found
though, that some of these genes were differentially expressed, so did not always exhibit
the constant, basal level of expression that was expected [14, 15]. It was found to be very
difficult to identify a set of genes whose expression does not change significantly under
any conditions. A more accepted method was to use one array as a reference, and another
which contained the treated samples [16]. In this way, all genes on the array had one
measurement with the expected normal level of expression, and another measurement
which was potentially different, as a result of some type of experimental treatment.
There are many factors that can contribute to systematic variability in two-color
spotted microarray experiments. One such source of variation is dye bias, where the Cy3
and Cy5 dyes have differing intensities of fluorescence. Quite often, the intensity for the
green dye is higher than that of the red dye, which can be caused by several different
issues, such as the heat and light sensitivity or relative half-life of the dye, efficiency of
incorporation, experimental variability in probe coupling and processing, or scanner
settings [14, 15]. Many times, dye bias has appeared to be spot-dependent, which can be
observed in plots of the log-ratio M vs. overall spot intensity A [14, 17]. To correct for
this, a paired-slides normalization process can be used. This only applies to experiments
where there is a dye-swap, in which there are two hybridizations for two mRNA samples,
with dye-assignments being reversed in the second hybridization. One method to do this
was proposed by Martin-Magniette et al. [18], where when the mean log-ratio was
defined as
log2(R1G2/G1R2)

Formula 1.1

where R1 is the intensity of the red dye on the first array, G2 is the intensity of the green
dye on the dye swap, G1 is the intensity of the green dye on the first array, and R2 is the
intensity of the red dye on the dye swap. It was shown that using Formula 1.1, no genes
were differentially expressed in a self-self hybridization [18]. Even using a dye-swap
though, it is still possible that some variance exists, which cannot be removed. This can
cause an increase in the false negative rate in an experiment, and subsequently decrease
the power of detection [18, 19].
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Another factor is a systematic variance of spots on the arrays as a result of
differences among print-tips. Such differences could include differences in the length or
opening of the tips, and deformation after extended periods of printing. Such variation is
corrected through a within-print-tip group normalization method, which is defined in
Formula 1.2 below,
log2 R/G -> log2 R/G – ci(A) = log2 R / (ki(A)G)

Formula 1.2

where ci(A) is the LOESS fit to the M vs. A plot for the ith grid on the array, and R and G
are the red and green intensities, respectively [14, 15]. Any negative values for R or G
will result in missing values for M and A, so are removed from further processing [20].
The LOESS scatter plot smoother performs a robust locally linear fit to the M-A plots,
and is not affected by a small percentage of differentially expressed genes, which appear
as outliers in the M-A plots [15, 21, 22]. A second source of variability within a slide is
the ratios of expression for genes with low intensities, which can also vary substantially
across experiments [23]. LOESS corrects for these effects as well though.
Another systematic source of variation lies in the differences inherent in using
multiple arrays in an experiment. Following the within-slide normalization, all of the
normalized log-ratios should be centered around zero, regardless of the method used to
do this. Different slides can have different spreads in their log-ratios, which may need to
be adjusted for through scaling [14]. A difference in the spread can result in the
misidentification of genes that are differentially expressed in the treatment group
compared to the control group [15]. Multiple-slide normalization attempts to correct for
different sample variances in the log ratios across slides. These adjustments are
necessary, so that the relative expression levels from one slide do not dominate the
average relative expression levels across replicate slides [15].
A final source of systematic variation lies in the errors that result from the
statistical tests used to identify differential expression. There is a constant tendency to
over- and under-estimate true expression values, and cannot be removed through replicate
analysis, since they are often highly reproducible [24]. This sometimes occurs with a
dye-gene interaction effect in a model. One method that attempts to correct this is the use
of a dye swap, although it must be noted that some errors are inherent in the statistical
analysis used [24].
IV. The Analysis of the Variability of Gene Expression
Variation could be defined in terms of variation between replicate arrays of the
same sample, or between replicate arrays of multiple samples from the same organism, or
replicate arrays from multiple organisms. Of particular interest though, is the amount of
variation that exists between animals in the same strain of a species, and the amount of
variation that exists between different species of the same genus. Oleksiak et. al. studied
this in different species of Fundulus in 2002, using two different geographically distinct
populations of the fish [25]. They applied ANOVA methods to loge normalized data, and
found that 161 genes (18%) were significantly different between individuals within the
same population (p < 0.01). For these genes, the difference in expression between two
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individuals within the same population typically varied by a factor of 1.5, but varied by
a factor of 2.0 or more for many genes [25]. From this, it can be concluded that two
individuals within the same population can have a large difference in their levels of
expression of the same gene. Oleksiak et. al. found that most of the variation between
populations of fish is a result of the variation present within a population. This is in line
with the neutral theory of evolution, which states that the variation between populations
is a positive function of the variation within populations [25].
This study was followed up in 2005 with another study by the same group, where
they investigated cardiac metabolism patterns of mRNA expression using microarrays
[26]. They found that in Fundulus heteroclitus, which is a natural outbred population of
fish, metabolism differed in individuals by greater than a factor of two. The expression
levels of 94% of the genes measured were significantly different (p < 0.01), as
determined by a nested ANOVA procedure with a Bonferroni correction [26]. It was also
found that the statistically significant differences in gene expression were not due to one
or a few individuals, or to experimental procedures. While there was a large amount of
variation within populations, it was found that the expression of only 10% of genes was
significantly different between populations, which provides additional evidence for the
substantial variation in gene expression within a species [26].
A third study on the teleost fish was performed by Whitehead et. al [27]. This
group found that 92 genes (48%) were differentially expressed among individuals within
a population/tissue group and that inter-individual differences ranged over fivefold. They
also found 146 genes (76%) that were differentially expressed among the brain, heart and
liver, as determine by an ANOVA test (p < 0.05) with Bonferroni correction.
Surprisingly though, only 31% of the tissue-specific differences was present in all three
populations of fish tested [27]. Additionally, only 6 genes (3%) had differential
expression among populations (p < 0.05), although this was cited to likely be an
underestimate [27].
Studies comparing gene expression between strains have been performed in the
two most popular model organisms for genetic dissection: Drosophila and
Saccharomyces. It was discovered by Rifkin et. al. that differences in gene activity in
Drosophila follow a phylogenetic pattern, and that 27% of all of the genes in the genome
differ in their developmental expression between at least two strains or species [28]. For
each gene in each strain, the differential expression along with confidence intervals was
estimated by a general linear model and bootstrap randomization. Rifkin et. al. found
2,193 genes that were highly variable through this method. Jin et. al. performed analysis
of Drosophila as well, through the use of sequential ANOVAs [29]. This group studied
the effects that sex, genotype and age had on transcriptional variance. They determined
that half of the genes exhibited sex-biased expression and 25% of genes may be
genotype-biased. The average contributions of sex and genotype were determined to be
60% and 33%, respectively [29]. Studies in yeast by Brem et. al. suggested that nearly
half of the yeast genome (2698 out of 6215 genes) is differentially expressed, as
determined by the Wilcoxon-Mann-Whitney test with bootstrap correction [30].
Similar studies have been completed in the mouse as well, although very little is
known about the normal amount of variation present [31]. Pritchard et. al found that 102
of 3,088 (3.3%) kidney genes, 62 of 3,252 (1.9%) testis genes, and 21 of 2,514 (0.8%)
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genes in the liver had statistically significant (p < 0.05) variable expression, as
determined by an ANOVA [31]. In this study, six normal male C57Bl6 mice were used,
and the variance across these six mice was compared to the variance among four replicate
experiments performed on each of the three tissues. Overall, they found that the kidney
and testis had larger F values than the liver, which suggests a higher amount of gene
expression variability in these tissues. Pritchard et. al. also considered whether or not
highly expressed genes will tend to have higher F values as a result of a greater variance,
but found that by plotting the F value vs. the intensity there was little correlation between
these variables [31]. The majority of the statistically significant variable genes had an
average intensity value near the mean of all expressed genes on the array.
While the study by Pritchard et. al. was informative about a basal amount of
variation in an inbred mouse strain, it only considered one strain and did not address the
amount of variation between different isogenic strains. It is well known that single
nucleotide polymorphisms (SNPs) play an important role in differentiating between
strains, and most likely contribute to the variability of gene expression as well [32, 33].
It has been found that up to 6% of the estimated 35,000 mouse genes contain blocks of
SNPs, which contribute to functional regulatory variation [33]. Turk et. al. studied the
variation of gene expression between several inbred mouse strains using an ANOVA
method. Only two mice from each strain were tested, and significance levels between
them were determined using a hierarchical t-test. False discovery rate was applied with a
p < 0.1 level of significance, and found 88 out of 6,144 (1.4%) expressed genes were
differentially expressed between strains [32]. A high correlation between gene
expression levels for the two samples of each strain was found, which indicates a low
amount of variation within the strains. The only tissue used in this study was the
hindlimb muscle tissue. Overall, Turk et. al. estimated that in this tissue, approximately
1.4% of the expressed genes show a differential expression between the different strains.
While the study by Turk et. al. only considered one tissue, a study by Pavlidis et. al.
analyzed six different brain regions in two mouse strains [34]. A two-factor ANOVA
and feature selection was performed to identify strain- and/or region-specific variation in
gene expression. Pavlidis et. al. identified 65 genes that showed strain-specific variation
(p < 10-5) in expression across all brain regions tested, and 600 genes (6%) that showed
region-specific variation (p < 10-5) [34]. A similar study was completed on the same data
set by Sandberg et. al., who found that approximately 1% of expressed genes are
significantly different between strains in at least one region of the brain [35]. In this
study, genes from one region were compared with all other brain regions using a
Student’s t-test (p < 0.05) to detect significant differences. A total of 73 genes were
found to be differentially expressed in at least one brain region between the two strains
(1.0%). No genes were found to be uniquely expressed in only one brain region, and
only 2 genes were found to be differentially expressed in comparisons of all duplicate
brain samples from the same strain [35].
The variation of gene expression has been addressed in humans as well by
Cheung et. al., who assessed natural variation in lymphoblastoid cells [36]. They
completed a genome-wide assessment of gene expression in humans by calculating a
variance ratio, or F statistic for each gene by dividing the variance of the expression
levels among individuals by the variance within microarray replicates. The variance
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ratios of 813 genes ranged from 0.4 to 64, with a median value of 2.5 and the variance
ratio within individuals ranged from 0.01 to 0.18. Cheung et. al. found that the 40 most
variable genes were not clustered in any chromosomal locations, but seemed to be
randomly scattered throughout the genome. They also assessed the functional
classification of the 100 most variable and 100 least variable genes through the use of the
Gene Ontology (GO). A chi-square analysis of the 8x2 contingency table was done to
identify significantly different functions (p < 0.025) for variable versus non-variable
genes. Many different categories were found to be significant in this comparison [36].
Even though there were no significant chromosomal clusters of highly variable genes, the
authors concluded that some of this variation was genetic.
One interesting study was completed by Enard et. al. [37], who considered the
intra- and inter-specific variation in primate gene expression patterns. All possible
comparisons between six human, six chimpanzee and two orangutan animals in both the
brain and liver were performed. Even though the test performed was more of a
phylogenetic analysis, which was performed by calculating a pair-wise distance between
two samples by summing the base-two logarithms of the absolute values of the fold
change of each gene, there were still some relevant inferences drawn. Enard et. al. found
that the amount of divergence of Mus spretus, Mus caroli from Mus musculus is in the
same order of magnitude as that of chimpanzees (1.08%) and orangutans (2.98%), from
humans [37].
An important factor to consider when investigating the variability of gene
expression in different strains or species is the underlying genetic variation. Chesler et.
al. estimated that with three replicate arrays per strain, that the amount of variance
accounted for by strain has a median of 11% and is as high as 78% across all transcripts
[38]. Differences in mRNA expression can be due to any number of factors, which not
only include genetic variation, but also complex interactions of environmental factors and
cell-cell interactions. The genetic variation is due to differences produced by cis-acting
polymorphisms, which are most commonly located in the gene’s promoter region, and by
trans-acting variants, which could be located anywhere throughout the genome [38].
Inbred mouse strains are particularly well known for having polymorphisms. In
alignment of the C57BL/6J to sequences from other strains, Wade et. al. found that there
are long segments of either extremely high (~40 SNPs per 10 kb) or extremely low (~0.5
SNPs per 10 kb) polymorphism rates [39]. Only one-third of the genome falls in the
category of long SNP segments. In looking at 50-kb segments of DNA, the observed
distribution of SNP rates was found to be noticeably non-random. This is in contrast to
the regions of low polymorphism rates, where the estimated rate of SNPs is one per
20,000 bp [39]. Comparison of common laboratory strains with B6 found that two-thirds
of the genome has very low polymorphism rates, which indicates that there are genomic
regions in the which the strains share a very recent common subspecies origin [39].
V. Clustering
Microarray technology has advanced to a state where it now can be considered
one of the primary tools for genomics research. Due to its high-throughput nature, and
ease of experimental design, the technology has exploded throughout the research
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community. While the experimental part of this technology has become fairly
standardized, there is still no clear-cut optimal method of analysis of the resultant data.
Tools to mine microarray data are still constantly being developed, although no perfect
solution is in sight. Every researcher seems to have their own favorite method of
analysis, which creates a major problem for the comparison of results across different
studies. While the bioinformatics community is attacking this problem with vigor,
constantly publishing new ways to analyze this type of data, there does not seem to be
any mainstream methods or standards being developed. Because of this, the ultimate
goal of the elucidation of gene networks through the use of microarrays is not yet
realistic.
Much of what is being done in terms of mining microarray data consists of
clustering data, or grouping genes together based upon similar patterns of expression.
This attempts to uncover meaningful relationships hidden in large, multivariate data sets.
Many different mathematical techniques have been applied to this end, with varying
amounts of success. While this problem is a popular topic for mathematicians and
statisticians, it has not yet been able to effectively incorporate biological knowledge on
the nature of the genes being clustered. There is no standard method to interpret gene
clusters for biological relevance, other than manual interpretation by biologists, which
can be time-consuming and difficult depending on the size and number of clusters
produced [40]. One increasingly common method in biology for assessing gene function
is through the use of the Gene Ontology (GO), which assigns “a dynamic, controlled
vocabulary that can be applied to all eukaryotes, even as knowledge of gene and protein
roles in cells is accumulating and changing” [41]. GO is represented as a directed acyclic
graph structure, which easily lends to a tree structure when applying a distance function
[40]. In this way, it can easily be integrated by clustering algorithms, to assess biological
significance.
Many different methods and classes of clustering algorithms exist in the literature.
Some have proven to be more popular than others, mostly based upon the ease of
implementation, and the number of citations in the literature to which new results can be
compared. Clustering techniques can be divided into hierarchical and non-hierarchical
methods. Hierarchical methods produce a group of nested classes, which can be easily
visualized in a tree (this resembles a phylogenetic classification) [42]. Hierarchical
clustering, specifically unweighted pair-group mean average (UPGMA) using a
correlation distance has become the most common method, and the standard to which all
other methods are compared against [43]. There are many different distance metrics that
can be applied to hierarchical clustering, each of which will yield distinct results.
Clustering algorithms can further be divided into divisive or agglomerative
techniques [42]. A divisive method begins by placing all of the genes into a single
cluster, which is gradually separated into smaller clusters. Agglomerative methods are
the opposite, in that each gene is initially its own cluster, and these smaller clusters are
gradually concatenated together to form larger clusters. These algorithms can be further
partitioned into supervised or unsupervised methods [42]. Supervised methods include
previously discovered biological information about the genes, and use this information as
a guide in the clustering process. Unsupervised algorithms are the more commonly used
method, as they cluster based only upon the normalized microarray data.
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The most commonly used unsupervised algorithm, and one of the first
statistical tests to be applied to the gene expression clustering problem is hierarchical
clustering. This algorithm produces a hierarchy of clusters, rather than a set number of
clusters fixed in advance. Initially, each observation forms its own cluster, and then at
each subsequent level, the two ‘nearest’ clusters are combined to form one bigger cluster.
There are many different metrics used with hierarchical clustering, to determine how
close one cluster is from another. The most common metric is the Euclidean distance,
which is a generalization of the Pythagorean Theorem. An average-linkage metric is
used to calculate the distance between clusters. One method of calculating the averages
is the unweighted pair-group method average (UPGMA). In this method, the average
distance is calculated from the distance between each point in a cluster, and all other
points in another cluster. The two clusters with the lowest average distance are joined
into a new cluster [42].
Another commonly used method of partitioning expression data is through kmeans clustering. This method requires a fixed number of clusters in advance. The
algorithm assigns the observations into k clusters in order to minimize the total withinclass sum of squares. Initially, all genes are randomly assigned to one of the k clusters.
Then an average expression vector is computed, and used to compute the distances
between clusters. Genes are then moved between clusters, to minimize intra-cluster
distance, and maximize inter-cluster distance. Moved genes remain in their new location
only if they are closer than to their previous cluster [42]. The number of clusters required
for this method is often determined by principal component analysis, or human intuition.
A popular variation to k-means clustering is Kohonen’s self-organizing maps
[44]. Self-organizing maps are a neural network-based approach, which assigns genes to
one of k partitions on the basis of the similarity of its expression vector to a reference
vector. The method of creating these reference vectors is what distinguishes this method
from standard k-means clustering. Reference vectors are created by training random
vectors in an iterative process that moves genes to a reference vector that is closest to the
gene [42]. While this method has become popular in the bioinformatics community, it
still presents the problem that k-means clustering has, in that it requires a predetermined
number of clusters, which is usually not a realistic expectation.
To alleviate this problem, Wang et. al. modified this algorithm and created double
self-organizing maps [45]. In this modification, each gene has two vectors, instead of
one – a weight vector and a position vector. Each time a gene is moved, both vectors are
updated, and the closer the weights are between two genes, then the closer their position
vectors will be. The number of clusters could then be determined by plotting the position
vectors, and visually inspecting the plots. This method was further modified by Ressom
et. al. in an algorithm named adaptive double self-organizing maps [46]. This method
performs clustering and cluster visualization simultaneously, thereby requiring no a
priori knowledge about the number of clusters. It is adaptive, because it updates its free
parameters during training, and it allows convergence of its position vectors to a fairly
consistent number of clusters, provided that its initial number of nodes is greater than the
expected number of clusters. This simplifies the clustering process from the user’s
standpoint, and removes any discrepancy in plot interpretation from double selforganizing maps.
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A commonly used method for partitioning data is through the use of graph
theory. Graph theory is a branch of mathematics and computer science that studies the
properties of collections of nodes and vertices. A large portion of computer science is
devoted towards this discipline, and has recently been applied to the problem of
clustering expression data. One such method uses minimum spanning trees [47]. A tree
is a common representation of a graph, and is the representation produced by a
dendrogram, such as is done in hierarchical clustering. The use of minimum spanning
trees converts a multidimensional clustering problem to a tree partitioning problem. Each
cluster is represented as a subtree, which does not overlap the representing tree of any
other cluster. In this method as with many of the clustering methods, a gene can be
represented in only one cluster, which is not a realistic expectation in a biological setting.
Another class of unsupervised algorithms that are gaining some attention are
fuzzy algorithms. These algorithms determine the relative likelihood of each gene
belonging to each of a number of clusters, thus providing information about a gene’s
multi-functionality. They also inherently account for noise in the data, because they
extract trends rather than precise values. While this is more meaningful biologically,
since these algorithms don’t use exact values, they are not as powerful statistically. Two
such algorithms are: fuzzy adaptive resonance theory (ART) [48] and fuzzy k-means
[49]. Fuzzy ART uses a neural network with back-propagation. Fuzzy k-means is an
extension of the k-means heuristic described above. Since it is fuzzy, it does not required
a predetermined number of clusters, but does risk the potential of getting stuck in a local
minimum of a poor value of the expression vector.
A majority of publications concerning the analysis of microarray data utilize
experiments that are done over a period of time. Since it is not as meaningful to assess
the expression changes of a single experiment, expression changes over time are often
compared to some basal expression level of the different genes of interest, which
indicates whether the gene exhibits a response to the treatment applied. The time-course
data from a single species is then combined into large matrices, and used as the basis for
clustering. While for many applications this is an adequate experimental design, it does
not take into account evolutionary conservation of function or regulation, and excludes
the use of sequence analysis tools. The integration of other biological data such as this,
with unsupervised clustering algorithms has not yet been addressed.
VI. Bayesian Networks
Bayesian statistics is a fairly new branch of probability theory, which has
exploded into many different areas of research. This field has found particular
application in the study of genetics data [50]. Applications in genetics have included
population genetics, sequence analysis, quantitative trait loci (QTL) analysis [51],
pedigree and multilocus linkage analysis [52] and the construction of phylogenetic trees
[53]. One particularly popular application of Bayesian statistics is the analysis of
microarray data, which includes analysis of differential expression, cluster analysis, and
regulatory networks [54]. Of particular interest in the present study, is the use of
Bayesian methods to construct gene regulatory networks. Bayesian networks have
received a good deal of attention in the last few years [55-58], not only with constructing
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regulatory networks, but also for their ability to incorporate proteomic data [59, 60].
Bayesian networks have been applied to both spatial and time-course data [58], in the
form of static and dynamic Bayesian networks, respectively. One important question in
building a Bayesian network though, is what is the minimal amount of data required to
attain an accurate model? Building a network that includes thousands of genes from
several dozen experiments is very difficult, since such a small number of arrays does not
suffice to distinguish between true correlations and false positives [57]. So an important
questions remains, what is the optimal number of experiments needed?
A Bayesian Network is a graph-based model of joint multivariate probability
distributions that captures properties of conditional independence between variables [55].
Such networks represent the dependence structure between multiple interacting quantities
(i.e. genes), and attempt to uncover the transcriptional events that regulate the expression
of genes. Bayesian networks are mathematically defined strictly in terms of probabilities
and conditional independence statements; however, this can easily be extrapolated to the
notion of direct causal influence [55]. A Bayesian network is simply a graphical way to
represent a particular factorization of a joint distribution [61]. Due to the inferred
causality present in the Bayesian Network structure, they naturally suggest control points
in signaling pathways, which is of great interest biologically [62].
A Bayesian network structure is simple to interpret: each node in the graph is
conditionally independent from its non-descendents given its parents [61]. Generally,
two disjoint sets of nodes A and B are considered conditionally independent given C, if C
d-separates A and B. In other words, if along every undirected path between a node in A
and a node in B, there is a node D, such that: (1) D has converging arrows and neither D
nor its descendents are in C, or (2) D does not have converging arrows and D is in C [61].
In this way, visual inspection of the graph of a Bayesian network is simple, and it is not
necessary to go through scores of graphs and more
mathematically rigorous methods of evaluation. An
example of these principles is depicted to the right in
W
Figure 1.2. Node W is conditionally independent from X
given the set C = {Y, Z}, since Y ε C is along the only path
between W and X, and Y does not have converging arrows.
From this graph though, it cannot be inferred that W is
X
Y
conditionally independent from X, given Z [61]. From this
example, it is also obvious that a directed, acyclic graph is
required. Each factorization computed in a Bayesian
Z
Network implies a strict ordering of the variables, so this
therefore forces the constraint of directed acyclicity upon
Figure 1.2: A
the model. However, this constraint is removed through
directed acyclic
the implementation of dynamic Bayesian Networks, which
graph, with the
allow for loops, such as regulatory feedback loops [63].
conditional
Dynamic methods are ideal for handling time series data,
independence
as well as modeling stochasticity, prior knowledge and
relations in
hidden variables [64].
P(W,X,Y,Z).
There are two different types of variables that can
exist in a Bayesian network, discrete and continuous. A
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discrete variable can contain values from a finite set. If a variable is binary (2 possible
values), then the table that specifies the probability of different possible values for the
node will specify 2k distributions. This immediately brings to light the complication in
creating a Bayesian network, which is the amount of data required. In using a discrete
variable, the number of free parameters is exponential in the number of parents [55]. The
other type of variable is a continuous variable. Unlike discrete variables, when a node
and its parents contain real values, there is no representation that can model all possible
densities. Therefore, a natural choice to represent these multivariate continuous
distributions would be to use Gaussian distributions. In a Bayesian Network, this
consists of using linear Gaussian conditional densities [55]. In doing this, the node is
distributed around a mean that depends linearly on the values of its parents. The variance
of this normal distribution is independent of the parents’ values. Both of these types of
nodes can be utilized in a single Bayesian Network, which is called a hybrid network.
This poses an important question of how to represent a conditional distribution for a
continuous variable with discrete parents, and for a discrete variable with continuous
parents [55]. To add to the complexity of variables in a Bayesian Network, variables can
also be observed or hidden. A variable that describes an observed value is an information
variable, while a variable describes an unobserved value is called a latent variable [65].
In learning a Bayesian Network, the most important question to consider is how to
evaluate the accuracy of each possible network, and how to identify the optimal graph.
One commonly used method is the Bayesian (or BDe) scoring metric. In this metric, the
posterior probability of a graph given the data is defined as:
S(G : D) = log P (G | D)
= log P (G | D) + log P (G) + C
P (D | G) = ∫ P(D | G, Θ) P (Θ | g) dΘ

Formula 1.3

where D is the training set, G is a Bayesian Network structure, C is some constant
independent of G and P (G) and P (Θ | G) are priors for G . This method includes a
penalty for model complexity, thereby guarding against over-fitting the model [65]. The
choice of priors determines the exact Bayesian score. Given a sufficiently large number
of samples, those graph structures that exactly capture all dependencies in the distribution
will receive, with high probability, a higher score than all other graphs. There are two
problems with this though: in biological applications there often is not a sufficiently large
number of samples, and the choice of the prior is of crucial importance, which is rarely
known [55, 66].
An alternative metric was thus developed, which is a heuristic that does not
require the existence of a defined prior. The Bayesian Information Criterion (BIC) score
converges to a target model, however this does not ensure that the target model is the true
data-generating distribution [67]. BIC is defined as:
BIC = -2 ln (ζ) + K log (n)

Formula 1.4
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where ζ is the maximum likelihood estimate, K is the number of estimable parameters
in the approximating model and n is the sample size [67]. BIC is known to be biased
when n is small, as an estimator of its target model.
Each prior in the network can be specified by two parameters: a prior network and
an effective sample size [55]. The prior network reflects the belief on the joint
distribution of the variables. The effective sample size reflects how strong the belief is in
the prior network. Once the prior is specified and the data is given, learning consists of
finding the graph that maximizes the score. This is known to be an NP-hard problem [55,
68], so heuristic methods are required. In most situations, graphs larger than 5 nodes are
uncomputable, however Koivisto et. al. were able to compute graphs of 25 nodes using
an algorithm based on dynamic programming [68]. Most commonly, local search
procedures are implemented to do this, where one edge at a time is added, removed or
reversed. Such methods include greedy hill-climbing, beam-search, stochastic hillclimbing, simulated annealing, K2, evolutionary algorithms and Markov Chain Monte
Carlo [55].
Markov Chain Monte Carlo (MCMC) methods are an improvement over other
Monte Carlo methods, such as importance sampling, where x random samples are drawn
from the prior and the distribution on the hidden variables and then the samples are
weighted by their likelihood, P (y | x) where y is the evidence. Markov Chain Monte
Carlo allows samples to be drawn from the posterior P (X | y), even when the
x
normalizing constant, ∫ P(y | x) P (x) can’t be computed [69]. MCMC is the most
dominant method used for approximate inference of Bayesian graph structure. Typically,
MCMC is applied to search over possible network structures, but it has recently been
shown that it is sometimes more effective to search over all possible variable orders [70].
Bayesian Networks have recently become a popular tool for modeling genetic
networks from noisy, high-throughput biological data. Bayesian Networks have the
ability to simultaneously model non-linear combinatorial relationships, and robustly
handle noisy data sets and guard against over-fitting [63, 71]. Since such networks
capture linear and nonlinear interactions between groups of variables, and at the same
time reduce the number of parameters required to describe the model, they are much
more successful than other similar modeling approaches [62]. Bayesian Networks are
also a great improvement over clustering methods, since Bayesian Networks can describe
arbitrary control of gene expression, and are thus not limited to pair-wise interactions
between genes [65]. In any experiment, only a subset of genes in a cluster may
contribute to its expression signature, and different gene clusters may have similar
signatures across the arrays, owing to either an overlap between the gene sets or coregulation of non-overlapping gene sets [72]. Because of this, it is hard to conclude that
such clusters actually correspond to pathways, as the expression profile is sometimes
considered only a weak indicator that genes participate in the same pathway [73]. As
such, many authors have considered incorporating alternative data sources, such as
protein-protein interactions [60, 73, 74], genetic sequence data [75] and cis-regulatory
elements [76], metabolic data [77], and human inference [64, 78, 79] to obtain more
accurate network models. In the converse of this, Bayesian Networks have also been
employed to predict protein-protein networks from genomic data [59].

16
Other methods for constructing Bayesian Networks from gene expression data
have consisted of limiting the size of network being learned. In this way, the larger
problem of network learning is broken down into smaller pieces, or modules, which can
later be combined into larger graphical structures. One such method attempted to only
learn the skeleton of the graph, which significantly restricted the search space of possible
graphical structures [80]. Another such method determined that motifs were more
reliable structures found in the expression data than entire networks, as determined by the
scoring method used [81]. The identification of motifs, or features, in a larger graph has
also been done with nonparametric bootstrapping [55] and greedy hill-climbing [82].
Clustering has also been attempted before network construction, to again attempt to limit
the search space [83].
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Chapter 2
Variability of gene expression in inbred mice strains in
response to low-dose radiation exposure
I. Abstract
The molecular responses to radiation exposure have been an active research topic
for many years. Most of this effort has been focused on large doses of radiation, such as
those experienced during a nuclear explosion or cancer treatment. Of equal importance
though, are the effects of low doses of radiation, which have received much less
attention. This study attempts to analyze the effects of low-dose radiation exposure on
different inbred mice strains, each of which represents a unique genetic constitution. The
genetic background was found to have a dramatic effect on the variability of gene
expression of the irradiated mice, with anywhere from 950 to 6900 genes significantly
variable. This effect was found to be more extreme in some strains compared to others,
as well as being much more prominent in skin tissue than spleen tissue. Additionally,
200 to 3500 of the genes found to have variable expression were only variable in one of
the inbred strains, which again show that the genetic background has an impact on
different responses to radiation exposure. It was also found that performing microarray
hybridizations using RNA that comes from multiple animals dramatically increases the
variability of gene expression, when compared to RNA that comes from a single animal.
II. Introduction
The response to radiation exposure is a topic that has been studied for many years,
in relation to different radiation sources. Cells are known to exhibit varying responses to
radiation exposure, depending upon the radiation dose, type of radiation, and genetic
constitution. Since most research studying the effects of radiation exposure has focused
on large doses, the cellular responses to low-doses of radiation are still fairly unknown.
The goal of this study is to discover and characterize genetically inter-individual variation
in response to low-dose radiation. In this study, inter-individual genetic variation is
achieved through the use of inbred mouse strains as a model organism. It is believed that
responses to low-dose radiation will differ among individuals because of differing genetic
backgrounds, and because of this, there will be variation in the expression of genes that
cooperate in the response pathways.
It has been known for more than 40 years that different strains of mice are
differentially susceptible to the effects of radiation [84]. The BALB/c strain is well
known to be sensitive to radiation, in particular it is known for being highly susceptible to
radiation-induced mammary cancer and its genomic instability [84]. A major part of this
sensitivity has been attributed to the deficiency in BALB/c to repair double-strand DNA
breaks [84]. Low-dose radiation also causes differing immune responses in C57BL/6 and
BALB/c, in that mitogen-induced proliferation of splenocytes in C57BL/6 is enhanced by
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pretreatment with low-dose radiation, whereas it is suppressed in BALB/c [84].
Examples such as these attest to the variability of responses to low-dose radiation due to
the genetic constitution.
Since responses to low-dose radiation treatment are not well known, it would not
be a worthwhile endeavor to look at differences in the expression of specific genes (such
as is done using an RT-PCR assay). Instead, high-throughput gene expression studies
can be done to assay most of the mouse genome. This will allow for the characterization
of many genes, both known and unknown. Of particular interest in this study, is not only
how the expression differs in genes between the different strains, but also how much
variability is present in the expression. It would be expected that since animals within the
same inbred strain are almost genetically identical, that their response to radiation
exposure would be identical as well. This can be assessed using a test similar to a oneway analysis of variance. Of related interest is how expression between the control and
treatment groups differ, as well as how it differs between tissues.
III. Methods
Experimental Design:
Mice used in this study were all born and raised at the Oak Ridge National
Laboratory William L. and Liane B. Russell Laboratory for Comparative and Functional
Genomics. Six inbred mice strains were used for this study: A/J, C3H, B6.C, BALBxJ,
Bl6Jx and DBA/2J. Each strain has a different genetic constitution from the others, while
mice of the same strain can be considered to be genetically identical. In this way, it is
possible to have replicate samples within the study, which come from the same genetic
background. Treated mice were exposed to 10 cGy of X-rays, when they were 10 weeks
of age. The mice were sacrificed 3.5 hours after exposure, and the tissue was stored at 80°C until used for RNA extraction. RNA was extracted from the spleen and skin
tissues, converted to cDNA and hybridized to custom microarrays designed using the
Mouse Oligonucleotide Library by Sigma-Genosys and Compugen. There were 26 slides
that were printed using the 15,000 oligonucleotide (oligo) version of this mouse library,
and the other 78 slides were printed with the 22,000 oligo version. The oligos were all 65
base pairs long. The 22,000 oligo version of this library included the entire 15,000 oligo
version. Each of the arrays printed from the 15,000 oligo library contained 15,120 spots.
There were three different types of spots on the array, with 144 spots that were left blank,
115 spots that contained only buffer, and 14,861 spots that contained oligos. Each of the
arrays printed from the 22,000 oligo version of the library contained 23,232 spots. There
were four types of spots on these arrays, with 865 spots left blank, 225 spots that
contained only buffer, 96 spots that contained alien (unknown) oligos, and 21,997 spots
that contained oligos.
A dye swap of each array was done as well, to account for incorporation
and quantum characteristics of the two dyes. The number of arrays used in each tissue is
listed in Table 2.1 below. Each array was hybridized with a pool of two RNA samples, 1
of which was hybridized with Cy3, and the other with Cy5. For each array, there is a
corresponding dye-swap, where the dye assignments are reversed. In Table 2.1, the dye
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Table 2.1: Number and type of arrays
Strain
A/J

Tissue Number of Arrays
Skin
4
4
Spleen 8
B6.C
Skin
8
6
Spleen 8
BALBxJ Skin
8
4
Spleen 8
Bl6Jx
Skin
8
4
Spleen 4
C3H
Skin
8
4
Spleen 6
DBA/2J Skin
4
4
Spleen 4

Array Type
22K
15K
22K
22K
15K
22K
22K
15K
22K
22K
15K
22K
22K
15K
22K
22K
15K
22K
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Table 2.2: Number and type of arrays used for the
study of a single animal versus a pooled sample.
Strain Tissue
B6.C Skin
Spleen
B6/J Skin
Spleen
C3H Skin
Spleen

Number of arrays
8
8
8
0
6
0

Array type
22K
22K
22K
22K
22K
22K

swap is counted as a separate array, so there are essentially half as many arrays in the
study as is listed in the table.
A second component of this study assessed the variability of gene expression of a RNA
sample taken from a single animal, and compared it to a sample taken from a four-animal
RNA pool. In this component, the pooled sample is labeled with Cy5, and the singleanimal sample is labeled with Cy3. There is then a dye-swap done, such that the pooledanimal sample is labeled with Cy3 and the single-animal sample is labeled with Cy5. In
Table 2.2, the dye swap also is counted as a separate array, so again there are essentially
half as many arrays in the study as is listed in the table.
Spot Extraction:
ImaGene was used to extract the intensity measurements from the scanned images
of the arrays, and to flag spots that may have been poor measurements. Empty spots
were flagged if they had a low expression of were entirely missing. If the measure value
was below a preset threshold, then a green “X” was marked on the image. Negative spots
were flagged if the signal mean was lower than the background mean. With these spots,
a green “-“ was marked on the spot on the image. Poor spots were identified by
comparing a background level to the local background level distribution over the entire
image, as identified by a t-test. The resulting p-value was subtracted from 1, and labeled
the “confidence in contamination presence”. Spots with a low confidence were flagged.
Lastly, some spots were manually flagged, which were not identified by the filters
described.
Normalization:
Before any analysis, the raw intensity values were normalized. This was done
through a series of steps in SAS, which attempted to remove within- and between-slide
variability. The first step in the normalization process for this data set was to reset some
of the flags in the skin data. During the spot extraction process, there were different
technicians who used varying sensitivities for flagging genes in ImaGene. Because of
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this, there were some arrays that had every single gene marked as being flagged,
empty, poor or negative. Normally, any genes marked are simply removed from the data
set, but since this would have removed entire arrays, a new procedure had to be
implemented to reset these. Genes marked as being empty or poor were reset in the skin
arrays, and then marked as empty if the signal mean was less than a cutoff value. The
cutoff was set as the median intensity plus three times the standard deviation of the
median of absolute deviation (madsd) of the buffer spots on the array.
After the flags were adjusted in the skin data, the signal of each spot was
calculated as the signal mean minus the background mean. The signal was then
transformed to a log2 scale. Following this, normality tests were applied to the data to
identify outliers. An outlier was defined as having the absolute value of its signal minus
the median value being greater than ten times the madsd.
Once the outliers were determined, these genes, along with the flagged genes
were removed from the data set. There were initially 4,410,432 measurements in the data
set. 7,597 measurements were outliers and removed, leaving 4,402,835 measurements.
1,347,131 spots were flagged and removed, which left 3,055,704 measurements in the
data set. Following this, the normality of the coefficient of variation was assessed.
While the removal of the flagged spots and outliers greatly decreased the skewness and
kurtosis of the data set, some still remained. Despite this, it was assumed that this didn’t
have a large effect on the data, and the data was treated as being from a normal
distribution (as recommended by Wolfinger et. al. [85]).
The second part of the normalization process was within-print-tip group
normalization. Each grid on the array was printed with the same print-tips. There are
some systematic effects that may exist on the array due to this, such as slight differences
in the length, and there may be some deformation of the tips after excessive printing [14].
Additionally, printing the arrays one group at a time may create spatial effects on the
slide. These effects are removed by using LOESS, which is a scatter plot smoother based
on local regression. The log ratio, M (treatment minus control) is plotted versus the
overall spot intensity, A (average of treatment plus control). The fraction of data used for
smoothing at each point was 30%. Once this adjustment was calculated for each point in
the scatter plot, half of the adjustment value was subtracted from the treatment point, and
the other half was added to the control point. The M and A values were re-calculated,
and 5,159 data points were removed due to missing M values. Scatter plots of the pre(left) and post-normalized (right) data were created, an example of which is shown in
Figure 2.1.
Following the within-print-tip group normalization, all of the log-ratios are
centered around zero for each slide. With that being done, a control data set was created.
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Figure 2.1: Example scatter plot of pre- and postwithin-print-tip group normalization.

This was done by taking the untreated Cy3 array, and merging it with the
untreated Cy5 array from the corresponding dye-swap. After the control data set was
created, a multiple slide normalization method was applied, which allowed comparisons
to be made between different experiments [14]. The data were normalized between slides
using a mixed model, with the normalized log mean of the dye being the dependent
variable in the model. Four of these models were used: one each for the skin and spleen
controls, and one each for the skin and spleen radiation data. In each of these models, the
only term in the model was the array. The model appears below in Formula 2.1,
dij = ϕi

Formula 2.1

where di is the log-normalized mean expression for dye j of gene i, and ϕI is the array.
The result of this model was a log-normalized residual for each of the two dyes for each
gene. Boxplots were created of the arrays, to show the effects of this part of the
normalization. An example is shown in Figure 2.2.
The final part of the normalization process was paired-slide normalization (dyeswap). For the controls data set, there was no dye-swap, so the normalized residual
values for the Cy3 and Cy5 measurements for each gene were simply averaged. The
ratios data set was normalized according to the results of Martin-Magniette et. al [18],
who showed through self-self hybridizations that using Formula 2.2, that no genes were
differentially expressed,
ri = R1G2/G1R2

Formula 2.2

where R1 is the Cy5 value from the treated part of the array, G2 is the Cy3 value from the
treated part of the array, G1 is the Cy3 value from the untreated part of the array and R2 is
the Cy5 value from untreated part of the array.
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Figure 2.2: Example boxplots of pre- and post-multiple slide normalization.

The genes on the arrays were cataloged according to their GenBank ID name, so each
gene with a GenBank ID had to be converted into an NCBI Gene ID, in order to map
chromosomal locations and Gene Ontology terms. On the arrays, there were 18,591
genes that had NCBI Gene ID’s, and 3,123 genes that did not.
Variance Ratio Calculation:
A variance component estimate was calculated for each gene in each strain using
Proc Mixed in SAS. The estimation method used was to compute the restricted/residual
maximum likelihood (REML) for each gene. This was done for each gene within each
strain and for that gene between the different strains as well. The variance ratio is then
defined as the REML estimate between the strains divided by the REML estimate within
the strain. This method is essentially analogous to a one-way Analysis of Variance
(ANOVA), which follows an F-distribution. Therefore, a p-value was calculated from an
F-distribution. Genes with a p-value < .05 were considered significant.
Formula 2.3 was used to calculate the REML estimate within a strain for a gene,
ri = αi + βi

Formula 2.3

where ri is the normalized residual for gene i, αi is the strain and βi is the gene id. In this
model, the strain is a random effect, and strain and gene id are categorical independent
variables in the model. Formula 2.4 was then used to calculate the REML estimate
between the strains for a gene,
REMLwithin = βi

Formula 2.4

where REMLwithin is the REML estimate for gene i within each strain, and βi is the gene
id. The variance ratio is then calculated as is shown below in Formula 2.4 [86]:
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REMLbetween
Var = ---------------REMLwithin

Formula 2.5

The p-values for the variance ratio of each gene in each strain was calculated using an Fdistribution, where the number of degrees of freedom in the numerator was one minus the
number of observations in Formula 2.4, and the number of degrees of freedom in the
denominator was one minus the number of observations in Formula 2.3. Critical Fvalues were calculated with a .05 level of significance as well. Genes with a p-value <
.05 were considered significant.
Differential Expression Between Treatment & Control Groups Calculation:
The differential expression of genes in the treatment group compared to the
control group was calculated using Proc Mixed in SAS. A paired t-test was calculated
using Formula 2.6, as follows:
ri = αi + γi + δi + αi*γi

Formula 2.6

where ri is the normalized residual for gene i, αi is the strain, γi is the treatment, δi is the
array and αi*γi is an interaction effect between the strain and treatment. In this model, the
array is a random effect, and treatment, strain and array are categorical independent
variables. This model was used for each tissue separately. A False discovery rate (FDR)
correction was then applied to the p-values [87], to attempt to control the proportion of
false-positives resulting from multiple comparisons. Genes with a p-value < .001 were
considered significant.
Differential Expression Between Strains Calculation:
The differential expression of genes between strains was calculated using Proc Mixed in
SAS. A paired t-test was calculated using Formula 2.7, as follows:
ri = αi + δi

Formula 2.7

where ri is the normalized residual for gene i, αi is the strain and δi is the array. In this
model, the array is a random effect, and strain and array are categorical independent
variables. This model was used for each tissue and treatment separately. A False
discovery rate correction was not applied to the p-values, since such a small number of
genes were significant (p-value < .05).
Clustering:
To cluster large sets of genes, the Hierarchical Ordered Partitioning and
Collapsing Hybrid (HOPACH) algorithm was implemented in the statistical package R.
The HOPACH algorithm builds a tree of clusters, where the clusters in each level of the
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tree are ordered based on the pairwise dissimilarities between cluster medoids [88].
HOPACH starts at the root node, and attempts to find the number of children for each
node by alternating partitioning steps with collapsing steps. In this way, it is a
combination of the two categories of clustering methods: agglomerative and partitioning,
and does not require a predefined number of clusters.
HOPACH creates a hierarchical tree, which it then unfolds through a series of
steps. First, the root node is partitioned, and the children in the next level are ordered
deterministically using the same dissimilarity matrix that is used for clustering. Next,
each of these nodes is partitioned, and its children are ordered. Before the next
partitioning step, collapsing steps merge any similar clusters. The process is iterated until
the main clusters are identified. The MSS criterion is used to automatically choose (i) the
number of children at each node, (ii) which clusters to collapse, and (iii) the level
containing the main clusters. Below the main clusters, the algorithm is run down without
collapsing to produce a final ordered list. The algorithm is described in more detail in
Pollard et. al [88].
HOPACH calculates clusters with both strict membership, and fuzzy membership.
Fuzzy clusters allow for genes to have some amount of membership in multiple clusters,
whereas clusters with strict membership permit genes to belong to one and only one
cluster. Fuzzy clusters are determined by proportions of bootstrap reappearance. For all
the applications of clustering in this study, clusters with fuzzy membership were used.
Since HOPACH determines the number of clusters present in the data, there are many
clusters of varying sizes created. Many of these clusters contain one to a few members,
which for this application is too few. Therefore, clusters with less than 10 genes in them
are combined together until a cluster of at least 20 is reached. Since the initial clusters
are fuzzy, a gene is considered a member if it has any amount of membership greater than
zero. If a cluster contains 10 or more genes, it remains as a separate cluster. Each cluster
was then run through Gene Ontology analysis as described below.
There are two typical figures produced to show the effects of the HOPACH
algorithm. The first is a plot of the ordered distance matrix and the second is a barplot of
the bootstrap reappearance proportions for each gene and each cluster. In the plot of the
ordered distance matrix, rows and columns of the dissimilarity matrix are ordered
according to their final level in the HOPACH hierarchical tree. Red color indicates a
small dissimilarity, and white color indicates a large dissimilarity, with red and white
correspond to positive and negative correlation, respectively. Yellow color indicates no
correlation. The second plot is a barplot of the bootstrap reappearance proportions for
each gene and each cluster. Each cluster is represented by a different color, and each
gene is represented by a narrow horizontal bar. The genes are ordered by HOPACH
cluster, and then by bootstrap estimated membership within a cluster and plotted on the
vertical axis. The length of each bar with a certain color is proportional to the percentage
of bootstrap samples in which that gene appeared in the cluster represented by that color.
If the bar is all or mostly one color, then the gene is estimated to belong strongly to that
cluster. If the bar is many colors, the gene has fuzzy membership in all these clusters.
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Chromosomal Clustering:
Clusters of genes on the mouse chromosomes were determined by plotting a
density distribution of genes in the statistical package R. This method is distinct from
previously used methods, which rely on a frequency count, or simple manual
interpretation [89-92]. The chromosome number, and gene start site was first obtained
for every gene in the set, and every gene in the mouse genome from GeneKeyDB [93]. A
list was then compiled of the start site of every gene on every mouse chromosome. A
density distribution was plotted for these, using the density function in R. This was also
done for the start sites of every gene in the set. The distribution for each chromosome
was plotted separately. On each of these plots in the Results section, the distribution for
the mouse genome is plotted in blue, and the distribution for the gene set is plotted in
green.
Then two permutations were done, to aid in determining regions of significance in
the genome. The first permutation consisted of randomly sampling the same number of
genes as was in the set for a given chromosome from all the genes on that chromosome in
the mouse. This was done 1,000 times, and the density curve was calculated each time.
The highest point in the density curve from each of the 1,000 samples was stored, and
these points were then sorted. The 10th highest point was then plotted in red on each
density plot, which is a .01 level of significance. The second permutation consisted of
randomly sampling the same number of genes as was in the set from the entire mouse
genome. This was done 1,000 times as well, and a density curve was calculated for each
chromosome. The highest point in the density curve for each chromosome was stored,
and these were subsequently sorted. A .01 level of significance was used for these as
well, which was obtained by multiplying the number of genes on a given chromosome in
the sample times .01. This was then rounded to an integer value, and was used as the
index to the vector of sorted points from the density curves. This was plotted in yellow
on each chromosome. Any parts of the density curve that met or exceeded both lines
from the permutations were considered significant.
Gene Ontology Analysis:
The analysis of a set of genes for enriched Gene Ontology (GO) terms was done
using a modified Perl implementation of the GoTree Machine [94]. Gene Ontology
categories with a significant number of genes were identified by comparing the
distribution of genes in the interesting gene set in each GO category to those of all the
genes on the array that had an NCBI Gene ID (the reference gene set). In calculating
this, there are n genes in the set of interest, and N genes on the array with NCBI Gene
ID’s. For any given GO category X, a gene from the set is either present or not. If K out
of N reference genes, and k out of n interesting genes are in category X, and if the n
genes are effectively a random sample uniformly selected from N, then the expected
value of k would be ke = (n/N)K. If k exceeds the expected value, the category X is
determined to be enriched, with a ratio of enrichment (R) given by R = k/ke. Since genes
can be selected only once, this is sampling without replacement and can be appropriately
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modeled by the hypergeometric distribution. The significance of enrichment (P) for a
given category is determined by Formula 2.6 [94] below.
n

p=Σ
i=k

( Nn-i-K ) ( Ki )

-----------------N
n

( )

Formula 2.6

Genes Ontology categories with a p-value of 0.01 or less were determined to be
significant. In addition, Bonferroni correction was used to adjust for multiple
comparisons. Terms were only considered significant if they had three or more genes
from the set of interest in them.
IV. Results
Figure 2.3 displays the number of significant genes in each strain and tissue for
the control and treatment groups. There is a significant increase in the number of genes
variable in the control versus treatment groups in each strain. In addition, the spleen
tissue seemed to have much less variability in gene expression than did the skin tissue.
Figure 2.4 plots REMLbetween vs. REMLwithin for the controls, and Figure 2.5 plots the
same thing for the treatment groups. There were several extreme outliers, which were
excluded from Figure 2.5. The lines in Figures 2.4 and 2.5 are calculated linear
regression lines. The REMLbetween and REMLwithin estimates are very small in the
controls (Figure 2.4) when compared to the treatment groups (Figure 2.5). Figure 2.4
also shows an interesting pattern, in that there seem to be a large number of genes with a
large REMLbetween and a small REMLwithin estimate, and also many genes that seem to
have a linear relationship between these two variables. In Figure 2.5 there appear to be
some genes that have a large REMLbetween and a small REMLwithin estimate, some genes
where there is a linear relationship between these two variables, while many genes that
have a large REMLwithin and a small REMLbetween estimate.
Figure 2.6 displays the number of genes that are differentially expressed (FDR p
< .001) in a paired test of the control and treatment group for each gene in each strain. As
with the analysis of the variance ratios, the spleen has significantly fewer genes
differentially expressed than does the skin tissue. Interestingly, Bl6Jx (7,539 genes) and
B6.C (7,500 genes) have a very large number of genes differentially expressed in the skin
tissue. Differential expression was also calculated between the different strains in each
tissue and treatment group. Figure 2.7 shows the number of genes significantly
differentially expressed (p < .01 without multiple comparison adjustment) in each paired
comparison in the control groups. Figure 2.8 has the same setup, with the treatment
groups. In the control group, there are anywhere from 0 to 12 genes found to be
differentially expressed between strains in each tissue. This range drops to be from 0 to 2
in the treatment group. There still seem to be some differences between the tissues,
although with such a small number of genes being significant, it is not possible to draw
any reliable conclusions. In the skin tissue, there are 1,563 genes found to be
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Figure 2.3: Number of genes in each strain and tissue with a statistically significant variance ratio (p < .05).
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Figure 2.4: REML estimate between strains vs. within strain for the control groups. Red points represent skin tissue
and green points represent spleen tissue.
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Figure 2.5: REML estimate between strains vs. within strain for the treatment groups. Red points represent skin tissue
and green points represent spleen tissue. Several extreme outliers were removed from this plot.
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Figure 2.6: The number of significantly differentially expressed genes between the
control and treatment groups in each strain and tissue.
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Figure 2.7: The number of significant differentially expressed genes between strains for each tissue
in the controls group.
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Figure 2.8: The number of significant differentially expressed genes between strains for each tissue in the
treatment group.
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differentially expressed in all 6 inbred mice strains, and in the spleen tissue, there were
654 genes found.
While the above figures show the number of genes that were differentially
expressed, and variable, one question of interest that arises is how many of the genes
found to be significant in these different statistical tests are common between genetically
distinct organisms, and how many are unique? Additionally, how many genes are
common between tissues? These issues are addressed through the subsequent figures and
tables. Table 2.3 displays the number of genes that have a significant variance ratio (p <
.01) in the control and treatment groups, between the different combinations of strains.
All possible combinations of strains were analyzed, and the only group that had genes
significantly variable in all six strains was the skin controls (10 genes). Table 2.4 contains
the number of genes that had a significant variance ratio in both the skin and spleen
tissues for the control and treatment groups. Very few genes were found to be in
common between strains and tissues in this test, and no genes were found to be in
common between both tissues and all strains in either the control or treatment groups.
Figure 2.9 displays the number of genes that had a significant variance ratio in
one and only one strain in either tissue or control or treatment groups. With the
exception of BALBxJ in the skin, and B6.C and Bl6Jx in the spleen, every strain shows
an increase in the number of variable genes between the control and treatment groups.
The number of genes differentially expressed in one and only one strain in the paired
comparison of control and treatment groups (Figure 2.10) was significantly less than the
number of genes shown in Figure 2.9. While the A/J strain was consistently similar in
the skin and spleen, the other strains had very few genes differentially expressed in the
spleen tissue. In combination of these two groups, as shown in Figure 2.11, there were
several genes significantly variable in both the control and treatment groups and
differentially expressed in a paired comparison between the two in one and only one
strain in the skin tissue. There were no such genes that met these criteria in the spleen
tissue.
Tests of differential expression between strains yielded very few significant
genes, as is shown in Figures 2.7 and 2.8. Even though there are so few genes, a test was
done to identify differentially expressed genes common to more than one strain. These
results are displayed in Table 2.5. There were a few genes found to be in common
between 2 paired comparisons between strains in the skin and spleen controls, but none in
the treatment groups. Table 2.6 is a complementing table, showing the number of genes
in common between strains in the test for differential expression between the control and
treatment groups.
Figures 2.12 and 2.13 show dendrograms produced from the hierarchical clustering of
arrays. In Figure 2.12, each array is included in the clustering, but the strains do not
seem to consistently cluster together, as would be expected. In Figure 2.13, the different
arrays for a strain are averaged together, to show the relationship between strains. These
do not seem to agree between the two tissues in either the control or treatment groups.

Table 2.3: The number of genes with a significant variance
ratio that are overlapping between strains.
C-Skin
3410
1030
1416
1544
1385
3129
525
699
745
635
1625
433
273
183
541
360
272
734
269
666
562
219
146
105
335
196
159
427
161
418
374
111
91
260
43
149
95
63
198
161
146
54
56
148
23
92
67
39
117
111
100
21
73
56
26
39
12
38
40
15
25
16
10

C-Spleen
1212
543
2074
934
1390
217
105
460
144
316
23
134
56
90
10
265
548
28
171
14
23
41
12
35
0
76
167
5
44
4
2
19
40
0
14
2
2
86
1
6
3
7
17
0
5
0
0
29
0
1
1
9
0
0
0
1
5
0
0
0
0
0
0

T-Skin
4723
6895
5654
5530
3297
4722
2213
1956
2286
1686
2487
3349
2546
1608
2340
2183
1420
2036
1712
2256
1681
1135
1135
832
1229
980
722
1030
958
1317
1046
1313
804
1261
876
1175
846
752
988
716
956
528
363
572
445
635
490
357
500
397
581
382
575
372
451
354
126
230
166
225
153
131
0

T-Spleen
2406
973
2771
1437
2134
3775
432
1093
694
879
1241
439
272
379
518
683
1075
1525
569
729
1164
229
166
204
239
379
485
615
334
388
490
158
221
247
145
142
218
336
394
647
311
95
114
106
89
74
104
192
208
259
165
91
71
114
61
177
52
28
38
24
80
26
0

Strain Combination
BALBxJ
Bl6Jx
B6.C
DBA/2J
A/J
C3H
BALBxJ and Bl6Jx
BALBxJ and B6.C
BALBxJ and DBA/2J
BALBxJ and A/J
BALBxJ and C3H
Bl6Jx and B6.C
Bl6Jx and DBA/2J
Bl6Jx and A/J
Bl6Jx and C3H
B6.C and DBA/2J
B6.C and A/J
B6.C and C3H
DBA/2J and A/J
DBA/2J and C3H
A/J and C3H
BALBxJ, Bl6Jx and B6.C
BALBxJ, Bl6Jx and DBA/2J
BALBxJ, Bl6Jx and A/J
BALBxJ, Bl6Jx and C3H
BALBxJ, B6.C and DBA/2J
BALBxJ, B6.C and A/J
BALBxJ, B6.C and C3H
BALBxJ, DBA/2J and A/J
BALBxJ, DBA/2J and C3H
BALBxJ, A/J and C3H
Bl6Jx, B6.C and DBA/2J
Bl6Jx, B6.C and A/J
Bl6Jx, B6.C and C3H
Bl6Jx, DBA/2J and A/J
Bl6Jx, DBA/2J and C3H
Bl6Jx, A/J and C3H
B6.C, DBA/2J and A/J
B6.C, DBA/2J and C3H
B6.C, A/J and C3H
DBA/2J, A/J and C3H
BALBxJ, Bl6Jx, B6.C and DBA/2J
BALBxJ, Bl6Jx, B6.C and A/J
BALBxJ, Bl6Jx, B6.C and C3H
BALBxJ, Bl6Jx, DBA/2J and A/J
BALBxJ, Bl6Jx, DBA/2J and C3H
BALBxJ, Bl6Jx, A/J and C3H
BALBxJ, B6.C, DBA/2J and A/J
BALBxJ, B6.C, DBA/2J and C3H
BALBxJ, B6.C, A/J and C3H
BALBxJ, DBA/2J, A/J and C3H
Bl6Jx, B6.C, DBA/2J and A/J
Bl6Jx, B6.C, DBA/2J and C3H
Bl6Jx, B6.C, A/J and C3H
Bl6Jx, DBA/2J, A/J and C3H
B6.C, DBA/2J, A/J and C3H
BALBxJ, Bl6Jx, B6.C, DBA/2J and A/J
BALBxJ, Bl6Jx, B6.C, DBA/2J and C3H
BALBxJ, Bl6Jx, B6.C, A/J and C3H
BALBxJ, Bl6Jx, DBA/2J, A/J and C3H
BALBxJ, B6.C, DBA/2J, A/J and C3H
Bl6Jx, B6.C, DBA/2J, A/J and C3H
BALBxJ, Bl6Jx, B6.C, DBA/2J, A/J and C3H
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Table 2.4: The number of genes with a significant variance ratio
in the skin and spleen that are overlapping between strains.
Control
115
10
32
24
57
17
6
16
0
5
0
0
0
0
0
0
2
0
6
0
1
2
0
1
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Treatment
544
297
730
403
381
867
56
98
36
73
111
75
78
35
57
43
106
356
23
41
205
11
56
9
4
24
18
55
14
18
37
18
13
29
17
12
13
5
19
106
8
11
0
0
9
4
0
0
5
18
2
5
2
13
5
5
0
0
0
0
0
0
0

Strain Combination
BALBxJ
Bl6Jx
B6.C
DBA/2J
A/J
C3H
BALBxJ and Bl6Jx
BALBxJ and B6.C
BALBxJ and DBA/2J
BALBxJ and A/J
BALBxJ and C3H
Bl6Jx and B6.C
Bl6Jx and DBA/2J
Bl6Jx and A/J
Bl6Jx and C3H
B6.C and DBA/2J
B6.C and A/J
B6.C and C3H
DBA/2J and A/J
DBA/2J and C3H
A/J and C3H
BALBxJ, Bl6Jx and B6.C
BALBxJ, Bl6Jx and DBA/2J
BALBxJ, Bl6Jx and A/J
BALBxJ, Bl6Jx and C3H
BALBxJ, B6.C and DBA/2J
BALBxJ, B6.C and A/J
BALBxJ, B6.C and C3H
BALBxJ, DBA/2J and A/J
BALBxJ, DBA/2J and C3H
BALBxJ, A/J and C3H
Bl6Jx, B6.C and DBA/2J
Bl6Jx, B6.C and A/J
Bl6Jx, B6.C and C3H
Bl6Jx, DBA/2J and A/J
Bl6Jx, DBA/2J and C3H
Bl6Jx, A/J and C3H
B6.C, DBA/2J and A/J
B6.C, DBA/2J and C3H
B6.C, A/J and C3H
DBA/2J, A/J and C3H
BALBxJ, Bl6Jx, B6.C and DBA/2J
BALBxJ, Bl6Jx, B6.C and A/J
BALBxJ, Bl6Jx, B6.C and C3H
BALBxJ, Bl6Jx, DBA/2J and A/J
BALBxJ, Bl6Jx, DBA/2J and C3H
BALBxJ, Bl6Jx, A/J and C3H
BALBxJ, B6.C, DBA/2J and A/J
BALBxJ, B6.C, DBA/2J and C3H
BALBxJ, B6.C, A/J and C3H
BALBxJ, DBA/2J, A/J and C3H
Bl6Jx, B6.C, DBA/2J and A/J
Bl6Jx, B6.C, DBA/2J and C3H
Bl6Jx, B6.C, A/J and C3H
Bl6Jx, DBA/2J, A/J and C3H
B6.C, DBA/2J, A/J and C3H
BALBxJ, Bl6Jx, B6.C, DBA/2J and A/J
BALBxJ, Bl6Jx, B6.C, DBA/2J and C3H
BALBxJ, Bl6Jx, B6.C, A/J and C3H
BALBxJ, Bl6Jx, DBA/2J, A/J and C3H
BALBxJ, B6.C, DBA/2J, A/J and C3H
Bl6Jx, B6.C, DBA/2J, A/J and C3H
BALBxJ, Bl6Jx, B6.C, DBA/2J, A/J and C3H
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Figure 2.9: The number of genes with a significant variance ratio that were unique to a particular
strain within each group.
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Figure 2.10: The number of genes significantly differentially expressed between the control and treatment groups,
which were unique to a particular strain in each of the two tissues.
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Figure 2.11: The number of genes significantly differentially expressed between the control and treatment groups and also
had a significant variance ratio, that were unique to a particular strain in each of the two tissues.
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Table 2.5: The number of genes differentially expressed
between strains.
C-Skin
11
0
9
0
0
12
3
12
7
11
0
0
11
9
0
0
1
0
0
0
0
0
0
0
0
2
0
0
2
1
0
0
0
0
0

C-Spleen
2
2
1
6
1
4
4
6
2
2
7
0
6
2
7
1
0
1
0
0
2
0
1
0
1
0
3
0
3
0
2
2
0
0
1

T-Skin
2
1
2
1
1
1
0
2
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

T-Spleen
1
0
2
0
1
0
1
0
0
1
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Strain Comparison
A/J and B6.C
A/J and BALBxJ
A/J and Bl6Jx
A/J and C3H
A/J and DBA/2J
B6.C and BALBxJ
B6.C and Bl6Jx
B6.C and C3H
B6.C and DBA/2J
BALBxJ and Bl6Jx
BALBxJ and C3H
BALBxJ and DBA/2J
Bl6Jx and C3H
Bl6Jx and DBA/2J
C3H and DBA/2J
A/J, B6.C and BALBxJ
A/J, B6.C and Bl6Jx
A/J, B6.C and C3H
A/J, B6.C and DBA/2J
A/J, BALBxJ and Bl6Jx
A/J, BALBxJ and C3H
A/J, BALBxJ and DBA/2J
A/J, Bl6Jx and C3H
A/J, Bl6Jx and DBA/2J
A/J, C3H and DBA/2J
B6.C, BALBxJ and Bl6Jx
B6.C, BALBxJ and C3H
B6.C, BALBxJ and DBA/2J
B6.C, Bl6Jx and C3H
B6.C, Bl6Jx and DBA/2J
B6.C, C3H and DBA/2J
BALBxJ, Bl6Jx and C3H
BALBxJ, Bl6Jx and DBA/2J
BALBxJ, C3H and DBA/2J
Bl6Jx, C3H and DBA/2J

Table 2.6: The number of genes differentially expressed
between the control and treatment groups.
Skin
3239
7539
7500
3720
1913
3189
3105
3150
2626
1700
2667
6614
3491
1818
3086
3546
1829
3114
1704
2615
1668
3093
2580
1686
2623
2608
1691
2645
1628
2347
1626
3451
1812
3068
1691
2564
1659
1697
2592
1662
1604
2578
1686
2620
1617
2336
1618
1621
2313
1621
1571
1691
2559
1659
1596
1599
1617
2312
1618
1563
1566
1596
1563

Spleen
1764
1138
1704
1049
1901
2239
987
1295
972
1366
1344
913
758
960
926
922
1360
1386
934
876
1437
875
751
907
856
881
1167
1119
892
833
1135
722
863
815
732
682
837
873
825
1171
816
715
840
790
726
676
805
840
794
1026
786
708
666
784
669
791
702
660
769
664
765
659
654

Strain Combination
BALBxJ
Bl6Jx
B6.C
DBA/2J
A/J
C3H
BALBxJ and Bl6Jx
BALBxJ and B6.C
BALBxJ and DBA/2J
BALBxJ and A/J
BALBxJ and C3H
Bl6Jx and B6.C
Bl6Jx and DBA/2J
Bl6Jx and A/J
Bl6Jx and C3H
B6.C and DBA/2J
B6.C and A/J
B6.C and C3H
DBA/2J and A/J
DBA/2J and C3H
A/J and C3H
BALBxJ, Bl6Jx and B6.C
BALBxJ, Bl6Jx and DBA/2J
BALBxJ, Bl6Jx and A/J
BALBxJ, Bl6Jx and C3H
BALBxJ, B6.C and DBA/2J
BALBxJ, B6.C and A/J
BALBxJ, B6.C and C3H
BALBxJ, DBA/2J and A/J
BALBxJ, DBA/2J and C3H
BALBxJ, A/J and C3H
Bl6Jx, B6.C and DBA/2J
Bl6Jx, B6.C and A/J
Bl6Jx, B6.C and C3H
Bl6Jx, DBA/2J and A/J
Bl6Jx, DBA/2J and C3H
Bl6Jx, A/J and C3H
B6.C, DBA/2J and A/J
B6.C, DBA/2J and C3H
B6.C, A/J and C3H
DBA/2J, A/J and C3H
BALBxJ, Bl6Jx, B6.C and DBA/2J
BALBxJ, Bl6Jx, B6.C and A/J
BALBxJ, Bl6Jx, B6.C and C3H
BALBxJ, Bl6Jx, DBA/2J and A/J
BALBxJ, Bl6Jx, DBA/2J and C3H
BALBxJ, Bl6Jx, A/J and C3H
BALBxJ, B6.C, DBA/2J and A/J
BALBxJ, B6.C, DBA/2J and C3H
BALBxJ, B6.C, A/J and C3H
BALBxJ, DBA/2J, A/J and C3H
Bl6Jx, B6.C, DBA/2J and A/J
Bl6Jx, B6.C, DBA/2J and C3H
Bl6Jx, B6.C, A/J and C3H
Bl6Jx, DBA/2J, A/J and C3H
B6.C, DBA/2J, A/J and C3H
BALBxJ, Bl6Jx, B6.C, DBA/2J and A/J
BALBxJ, Bl6Jx, B6.C, DBA/2J and C3H
BALBxJ, Bl6Jx, B6.C, A/J and C3H
BALBxJ, Bl6Jx, DBA/2J, A/J and C3H
BALBxJ, B6.C, DBA/2J, A/J and C3H
Bl6Jx, B6.C, DBA/2J, A/J and C3H
BALBxJ, Bl6Jx, B6.C, DBA/2J, A/J and C3H
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Figure 2.12: Hierarchical clustering of arrays. Top Left: Skin Controls, Top Right:
Spleen Controls, Bottom Left: Skin Treatment, Bottom Right: Spleen Treatment.
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Figure 2.13: Hierarchical clustering of strains with arrays averaged. Top Left: Skin
Controls, Top Right: Spleen Controls, Bottom Left: Skin Treatment, Bottom Right:
Spleen Treatment.
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Gene Set Analysis:
There were many different combinations of the above results created, and subsequently
analyzed for significance. The results of the analysis of each set are detailed in the
following section.
1. Genes with a significant variance ratio and were common between 6 of 6 strains in the
skin control. There were 10 genes in this set, all of which had a Gene ID. 4 of these 10
genes did not have a chromosomal location assigned. There were no chromosomes with
three or more genes, so density plots were not created. There were 7 genes that did not
have Gene Ontology annotations, and from the remaining 3 genes in the set, no Gene
Ontology categories were enriched.
2. Genes with a significant variance ratio and were common between 5 of 6 strains in the
spleen control. There were 5 genes in this set, all of which had a Gene ID. There were
no chromosomes with three or more genes, so density plots were not created. There were
2 genes that did not have Gene Ontology annotations, and from the remaining 3 genes in
the set, no Gene Ontology categories were enriched.
3. Genes with a significant variance ratio in 5 of 6 strains in the skin treatment group.
There were 1,031 genes in this set, 173 of which did not have a Gene ID. This reduced
the set to 858 genes, 151 of which did not have an assigned chromosomal location. The
gene density plots of each chromosome are in Figure 2.15. There were no gene-dense
regions found on any of the chromosomes from this set.
Since this set was so large, clustering was performed using the HOPACH
algorithm. There were three variables used for clustering: the average variance ratio for
the 5 strains, the maximum variance ratio and the range of the variance ratios. From this
data, the HOPACH algorithm identified 190 main clusters in the 5th level of the tree, with
a median split silhouette of 0.2848881. Figure 2.14 shows the ordered distance matrix
of the genes in the set. The overwhelming amount of red in the plot signifies that there is
very little dissimilarity between the genes in the set, and between clusters. There are
some genes that apparently have no correlation as indicated by the yellow regions.
Figure 2.14 also shows the barplot of the bootstrap reappearance proportions. Most
genes belong to the first cluster, as indicated by the red vertical bar on the left-hand side
of the plot. Most genes appear in 3 to 4 different clusters, at varying proportions.
Since there were so many clusters derived by HOPACH, clusters with less than 10
genes in them were combined into clusters of 20 or more genes, as described in the
Methods section. This yielded 124 clusters that had at least 10 genes each in them. From
this set, there were 209 genes that did not have Gene Ontology annotations. Each cluster
was analyzed for enriched terms, as described in the Methods section. There were three
terms found to be enriched: cytokine and chemokine mediated signaling pathway
(biological process), heparin binding (molecular function), and integrin-mediated
signaling pathway (biological process).
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Figure 2.14: Ordered
rdered distance matrix and bootstrap reappearance proportions of genes with
a significant variance ratio that were common between 5 of 6 strains in the skin treatment
group.
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Figure 2.15: Gene density plots of genes with a significant variance ratio and were common between 5 of 6 strains in
the skin treatment group.
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4. Genes with a significant variance ratio in 5 of 6 strains in the spleen treatment
group. There were 248 genes in this set, 24 of which didn’t have a Gene ID. This
reduced the set to 224 genes, 23 of which did not have an assigned chromosomal
location. The gene density plots of each chromosome are in Figure 2.17. There were no
gene-dense regions found on any of the chromosomes from this set.
Since this set was so large, clustering was performed using the HOPACH
algorithm. There were three variables used for clustering: the average variance ratio for
the 5 strains, the maximum variance ratio and the range of the variance ratios. From this
data, the HOPACH algorithm identified 65 main clusters in the 5th level of the tree, with
a median split silhouette of 0.3077117. Figure 2.16 shows the ordered distance matrix of
the genes in this set. Almost all of the genes have a positive correlation (very little
dissimilarity), although there are a few that have no correlation. Figure 2.16 also shows
the barplot of the bootstrap reappearance proportions. Very few of the genes in this set
belong to only one cluster, although most genes seem to be a large component of one
cluster, and small components of several others.
Since there were so many clusters derived by HOPACH, clusters with less than 10
genes in them were combined into clusters of 20 or more genes, as described in the
Methods section. This yielded 28 clusters that had at least 10 genes each in them. From
this set, there were 22 genes that did not have Gene Ontology annotations. Each cluster
was analyzed for enriched terms, as described in the Methods section, but no terms were
found to be enriched in this set.
5. Genes with significant variance between the strains, but not within the strain in the
skin treatment group (within strain variance < 20,000 and between strain variance >
100,000). There were 55 genes in this set, 7 of which did not have a Gene ID. This
reduced the set to 48 genes, 7 of which did not have an assigned chromosomal location.
The gene density plots of each chromosome are in Figure 2.19. There were no genedense regions found on any of the chromosomes from this set.
Since this set was somewhat large, clustering was performed using the HOPACH
algorithm. There were three variables used for clustering: the average variance ratio for
the strains, the maximum variance ratio and the range of the variance ratios. From this
data, the HOPACH algorithm identified 18 main clusters in the 3rd level of the tree, with
a median split silhouette of 0.1860477. Figure 2.18 shows the ordered distance matrix of
the genes in this set. Many of the genes have a positive correlation (very little
dissimilarity), although there are about equally as many that have no correlation. Figure
2.18 also shows the barplot of the bootstrap reappearance proportions. About half of the
genes in this set belong to only one cluster, and the other half of the genes belong to two
or three clusters.
Since there were so many clusters derived by HOPACH, clusters with less than 10
genes in them were combined into clusters of 20 or more genes, as described in the
Methods section. This yielded 3 clusters that had at least 10 genes each in them. From
this set, there were 14 genes that did not have Gene Ontology annotations. Each cluster
was analyzed for enriched terms, as described in the Methods section, but no terms were
found to be enriched in this set.

48

Figure 2.16: Ordered
ed distance matrix and bootstrap reappearance proportions of
genes with a significant variance ratio in 5 of 6 strains in the spleen treatment group.
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Figure 2.17: Gene density plots of genes with a significant variance ratio in 5 of 6 strains in the spleen treatment
group.
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Figure 2.18: Ordered
rdered distance matrix and bootstrap reappearance proportions of
genes with significant variance between the strains, but not within the strains in the
skin treatment group.
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Figure 2.19: Gene density plots of genes with significant variance between the strains, but not within in the skin treatment
group (within strain variance < 20,000 and between strain variance > 100,000).
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6. Genes with significant variance between the strains, but not within the strain in the
spleen treatment group (within strain variance < 20,000 and between strain variance >
100,000). There were 34 genes in this set, 3 of which didn’t have a Gene ID. This
reduced the set to 31 genes, all of which had an assigned chromosomal location. The
gene density plots of each chromosome are in Figure 2.20. There were no gene-dense
regions found on any of the chromosomes from this set. Since there were such a small
number of genes in the set, clustering was not performed. 5 of these genes did not have
an assigned Gene Ontology annotation. There was no Gene Ontology terms found to be
enriched in this set.
7. Genes with a significant variance ratio in the treatment group, but not in the control
group in the skin tissue, in 5 of the 6 strains. There were 865 genes in this set, 151 of
which didn’t have a Gene ID. This reduced the set to 714 genes, 96 of which did not
have a chromosomal location. The gene density plots of each chromosome are in Figure
2.22. There were no gene-dense regions found on any of the chromosomes from this set.
Since this set was so large, clustering was performed using the HOPACH
algorithm. There were three variables used for clustering: the average variance ratio for
the strains, the maximum variance ratio and the range of the variance ratios. From this
data, the HOPACH algorithm identified 90 main clusters in the 6th level of the tree, with
a median split silhouette of 0.345169. Figure 2.21 shows the ordered distance matrix of
the genes in this set. Many of the genes have a positive correlation (very little
dissimilarity), although the inner branches don’t seem to have any correlation with the
outer branches of the HOPACH tree. Figure 2.21 also shows the barplot of the bootstrap
reappearance proportions. Interestingly, almost all of the genes have 10% of their
reappearance proportion in the same cluster. Most genes belong to 3-4 clusters in this
set.
Since there were so many clusters derived by HOPACH, clusters with less than 10
genes in them were combined into clusters of 20 or more genes, as described in the
Methods section. This yielded 81 clusters that had at least 10 genes each in them. From
this set, there were 159 genes that did not have Gene Ontology annotations. Each cluster
was analyzed for enriched terms, as described in the Methods section, and four terms
were found to be enriched: male sex differentiation (biological process), integrinmediated signaling pathway (biological process), external side of plasma membrane
(cellular components) and cell surface (cellular components).
8. Genes with a significant variance ratio in the treatment group, but not in the control
group in the spleen tissue, in 5 of 6 strains. There were 146 genes in this set, 12 of which
did not have a Gene ID. This reduced the set to 134 genes, 12 of which did not have a
chromosomal location. The gene density plots of each chromosome are in Figure 2.24.
There were no gene-dense regions found on any of the chromosomes from this set.
Since this set was so large, clustering was done using the HOPACH algorithm. There
were three variables used for clustering: the average variance ratio for the strains, the
maximum variance ratio and the range of the variance ratios. From this data, the
HOPACH algorithm identified 52 main clusters in the 3th level of the tree, with a median
split silhouette of 0.2230841. Figure 2.23 shows the ordered distance matrix of the genes
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Figure 2.20: Gene density plots of genes with significant variance between the strains, but not within in the spleen
treatment group (within strain variance < 20,000 and between strain variance > 100,000).
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Figure 2.21: Ordered distance matrix and bootstrap reappearance proportions of
genes with a significant variance ratio in the treatment group, but not in the control
group in the skin tissue, in 5 of 6 strains.
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Figure 2.22: Gene density plots of genes with a significant variance ratio in the treatment group, but not in the
control group in the skin tissue, in 5 of 6 strains.
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Figure 2.23: Ordered distance matrix and bootstrap reappearance proportions of
genes with a significant variance ratio in the treatment group, but not in the control
group in the spleen tissue, and common between 5 of 6 strains.
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Figure 2.24: Gene density plots of genes with a significant variance ratio in the treatment group, but not in the
control group in the spleen tissue, in 5 of 6 strains.
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in this set. Almost all of the genes have a positive correlation (very little dissimilarity),
although there are some in the outer branches of the HOPACH tree that have no
correlation. Figure 2.23 also shows the barplot of the bootstrap reappearance
proportions. Most of the genes in this set below to three different clusters, although
genes in the first 5 HOPACH clusters belong to only one cluster.
Since there were so many clusters derived by HOPACH, clusters with less than 10
genes in them were combined into clusters of 20 or more genes, as described in the
Methods section. This yielded 15 clusters that had at least 10 genes each in them. From
this set, there were 9 genes that did not have Gene Ontology annotations. Each cluster
was analyzed for enriched terms, as described in the Methods section, but no terms were
found to be enriched in this set.
9. Genes with a significant variance ratio in the control and treatment groups, and
differential expression between these groups in the skin tissue. There were 689 genes in
the set, 51 of which did not have a Gene ID. This reduced the set to 638 genes, 288 of
which did not have an assigned chromosomal location. The gene density plots of each
chromosome are in Figure 2.25. There were two regions found to be gene-dense on the
genome: one on chromosome 3 and the other on chromosome 11.
The peak of the density curve on chromosome 3 spans 2.5 megabases, in which
there are 9 genes from the 12 genes in the set on the chromosome. The genes under the
curve are the following: RIKEN cDNA 6330415M09 gene, farnesyl diphosphate
synthetase, RIKEN cDNA 4932431F02 gene, RIKEN cDNA 4932431F02 gene, RIKEN
cDNA 1110058A15 gene, mitochondrial ribosomal protein L9, RIKEN cDNA
2310007A19 gene, RIKEN cDNA 2610022K04 gene and CDC42 small effector 1.
These genes had start sites of 88863530, 91299735, 92413789, 92413789, 95637164,
97141147, 97162792, 97835296 and 97929318 respectively. Four of these 9 genes were
not annotated with Gene Ontology categories, and no categories were found to be
enriched.
The peak of the density curve on chromosome 11 spans 5 megabases, in which
there are 14 genes from the 22 genes on the chromosome. The genes under the curve are
the following: peripheral myelin protein, RIKEN cDNA 4632403M07 gene, RIKEN
cDNA 1700095G12 gene, solute carrier family 25 (mitochondrial carrier oxoglutarate
carrier) member 11, MIS12 homolog (yeast), RIKEN cDNA 1200014J11 gene,
carbohydrate kinase-like, RIKEN cDNA 0610007A15 gene, DNA segment Chr 11,
ERATO Doi 530 expressed, RIKEN cDNA 5730455P16 gene, acetyl-Coenzyme A
carboxylase, RIKEN cDNA 1110001A07 gene, RIKEN cDNA 4732452J19 gene, and
splicing factor arginine/serine-rich 1 (ASF/SF2). These genes had start sites of
62702778, 69374882, 69392138, 70215466, 70590877, 72619145, 72770747, 77750031,
79564371, 79932720, 83786523, 86669632, 87260268 and 87608150 respectively. Six
of these 14 genes were not annotated with a Gene Ontology category, and zero categories
were enriched in the remaining 8 genes.
Since this set was so large, clustering was performed using the HOPACH
algorithm. There were three variables used for clustering: the t-test value, the variance
ratio from the control group and the variance ratio from the treatment group. From this
data, the HOPACH algorithm identified 81 main clusters in the 6th level of the tree, with

59

Figure 2.25: Gene density plots of genes with a significant variance ratio in the control and treatment groups,
and was differentially expressed between these groups in the skin tissue.
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a median split silhouette of 0.2742538. Figure 2.26 shows the ordered distance matrix
of the genes in this set. Some of the genes in the middle branches of the HOPACH tree
positively correlate with each other, but the outer and inner-most branches of the tree
don’t correlate with themselves or each other. Figure 2.26 also shows the barplot of the
bootstrap reappearance proportions. Almost all of the genes belong to the first HOPACH
cluster. Most of the genes are in at least 5 different clusters, and only a few belong
exclusively to one cluster.
Since there were so many clusters derived by HOPACH, clusters with less than 10
genes in them were combined into clusters of 20 or more genes, as described in the
Methods section. This yielded 68 clusters that had at least 10 genes each in them. From
this set, there were no genes that did not have Gene Ontology annotations. Each cluster
was analyzed for enriched terms, as described in the Methods section, but no terms were
found to be enriched in this set.
10. Genes that were significantly differentially expressed between the control and
treatment groups, in all six strains in the skin tissue. There were 1,563 genes in this set,
233 of which did not have a Gene ID. This reduced the set to 1,330 genes, 372 of which
did not have an assigned chromosomal location. The gene density plots of each
chromosome are in Figure 2.28. There were no gene-dense regions found on any of the
chromosomes from this set.
Since this set was so large, clustering was performed using the HOPACH
algorithm. There were three variables used for clustering: the average t-value for the
strains, the maximum t-value and the range of the t-values. From this data, the HOPACH
algorithm identified 81 main clusters in the 6th level of the tree, with a median split
silhouette of 0.2742538. Figure 2.27 shows the ordered distance matrix of the genes in
this set. A majority of the clusters positively correlate with each other, although the outer
branches of the HOPACH tree negatively correlate, while the branches just inside of
those don’t correlate at all with each other. Figure 2.27 also shows the barplot of the
bootstrap reappearance proportions. Almost all of the genes belong to the first HOPACH
cluster. Most of the genes are in at least 5 different clusters, and none of them belong
exclusively to one cluster. There are a group of genes that have only a small
reappearance proportion in the first cluster, then the remainder in another common
cluster.
Since there were so many clusters derived by HOPACH, clusters with less than 10
genes in them were combined into clusters of 20 or more genes, as described in the
Methods section. This yielded 117 clusters that had at least 10 genes each in them. From
this set, there were 471 genes that did not have Gene Ontology annotations. Each cluster
was analyzed for enriched terms, as described in the Methods section, and only one term
was found to be significantly enriched: molecular function unknown (molecular
function).
11. Genes that were significantly differentially expressed between the control and
treatment groups, in all six of the strains in the spleen tissue. There were 655 genes in
this set, 98 of which did not have a Gene ID. This reduced the set to 557 genes, 49 of
which did not have an assigned chromosomal location. The gene density plots of each
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Figure 2.26: Ordered distance matrix and bootstrap reappearance proportions of
genes with a significant variance ratio in the control and treatment groups, and was
differentially expressed between these groups in the skin tissue.
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Figure 2.27: Ordered distance
ance matrix and bootstrap reappearance proportions of genes
that were significantly differentially expressed between the control and treatment groups,
in all of the strains in the skin tissue.
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Figure 2.28: Gene density plots of genes significantly differentially expressed between the control and treatment
groups, in all of the strains in the skin tissue.
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chromosome are in Figure 2.30. There were no gene-dense regions found on any of
the chromosomes from this set.
Since this set was so large, clustering was performed using the HOPACH
algorithm. There were three variables used for clustering: the average t-value for the
strains, the maximum t-value and the range of the t-values. From this data, the HOPACH
algorithm identified 102 main clusters in the 6th level of the tree, with a median split
silhouette of 0.2677498. Figure 2.29 shows the ordered distance matrix of the genes in
this set. A majority of the clusters positively correlate with each other, although the outer
branches of the HOPACH tree negatively correlate, while the branches just inside of
those don’t correlate at all with each other. Figure 2.29 also shows the barplot of the
bootstrap reappearance proportions. Many of the genes belong to the first HOPACH
cluster. Most of the genes are in 2 or 3 different clusters, and none belong exclusively to
one cluster.
Since there were so many clusters derived by HOPACH, clusters with less than 10
genes in them were combined into clusters of 20 or more genes, as described in the
Methods section. This yielded 53 clusters that had at least 10 genes each in them. From
this set, there were 75 genes that did not have Gene Ontology annotations. Each cluster
was analyzed for enriched terms, as described in the Methods section, but no terms were
found to be enriched in this set.
12. Genes that had a significant variance ratio in one and only one strain in the skin
control group. There were 3,023 genes in this set, 295 of which did not have a Gene ID.
This reduced the set to 2,728 genes, 1,056 of which did not have an assigned
chromosomal location. The gene density plots of each chromosome are in Figure 2.32.
There were no gene-dense regions found on any of the chromosomes from this set.
Since this set was extremely large, clustering was performed using the HOPACH
algorithm. There was only one variable available for clustering with this set, which was
the variance ratio for each significant gene in the strain. From this data, the HOPACH
algorithm identified 2 main clusters in the 1st level of the tree, with a median split
silhouette of -0.3825825. Figure 2.31 shows the ordered distance matrix of the genes in
this set. There are no major trends of clusters not correlating with each other – it appears
that almost all of the clusters have a positive correlation with one another. Figure 2.31
also shows the barplot of the bootstrap reappearance proportions. From this plot, all of
the genes belong entirely to the same cluster, so bootstrap had no effect on the data.
Since both of the clusters found by HOPACH had more than 10 genes in them, no
new clusters needed to be created. There were 1,435 genes in this set that were not
annotated with Gene Ontology terms, and no terms were found to be enriched in either
cluster.
13. Genes that had a significant variance ratio in one and only one strain in the spleen
control group. There were 3,019 genes in this set, 364 of which did not have a Gene ID.
This reduced the set to 2,655 genes, 263 of which did not have an assigned chromosomal
location. The gene density plots of each chromosome are in Figure 2.33. There were no
gene-dense regions found on any of the chromosomes from this set.
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Figure 2.29: Ordered
red distance matrix and bootstrap reappearance proportions of
genes that were significantly differentially expressed between the control and
treatment groups, in all of the strains in the spleen tissue.
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Figure 2.30: Gene density plots of genes significantly differentially expressed between the control and treatment
groups, in all 6 strains in the spleen tissue.
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Figure 2.31: Ordered distance matrix and bootstrap reappearance proportions of
genes that had a significant variance ratio in one and only one strain in the skin
control group.
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Figure 2.32: Gene density plots of genes that have a significant variance ratio in one and only one strain in the skin
control group.
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Figure 2.33: Gene density plots of genes that have a significant variance ratio in one and only one strain in the spleen control
group.
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Since this set was extremely large, clustering was done using the HOPACH
algorithm. There was only one variable available for clustering with this set, which was
the variance ratio for each significant gene in the strain. From this data, the HOPACH
algorithm identified 2 main clusters in the 1st level of the tree, with a median split
silhouette of -0.3333333. Figure 2.34 shows the ordered distance matrix of the genes in
this set. There are no major trends of clusters not correlating with each other – it appears
that almost all of the clusters have a positive correlation with one another. Figure 2.34
also shows the barplot of the bootstrap reappearance proportions. From this plot, all of
the genes belong entirely to the same cluster, so bootstrap had no effect on the data.
Since both of the clusters found by HOPACH had more than 10 genes in them, no
new clusters needed to be created. There were 441 genes in this set that were not
annotated with Gene Ontology terms, and no terms were found to be enriched in either
cluster.
14. Genes that had a significant variance ratio in one and only one strain in the skin
treatment group. There were 4,663 genes in this set, 624 of which did not have a Gene
ID. This reduced the set to 4,039 genes, 1,133 of which did not have an assigned
chromosomal location. The gene density plots of each chromosome are in Figure 2.36.
There were no gene-dense regions found on any of the chromosomes from this set.
Since this set was extremely large, clustering was done using the HOPACH
algorithm. There was only one variable available for clustering with this set, which was
the variance ratio for each significant gene in the strain. From this data, the HOPACH
algorithm identified 2 main clusters in the 1st level of the tree, with a median split
silhouette of -0.3928058. Figure 2.35 shows the ordered distance matrix of the genes in
this set. There are no major trends of clusters not correlating with each other – it appears
that almost all of the clusters have a positive correlation with one another. Figure 2.35
also shows the barplot of the bootstrap reappearance proportions. From this plot, all of
the genes belong entirely to the same cluster, so bootstrap had no effect on the data.
Since both of the clusters found by HOPACH had more than 10 genes in them, no
new clusters needed to be created. There were 1,638 genes in this set that were not
annotated with Gene Ontology terms, and no terms were found to be enriched in either
cluster.
15. Genes that had a significant variance ratio in one and only one strain in the spleen
treatment group. There were 2,716 genes in this set, 341 of which did not have a Gene
ID. This reduced the set to 2,375 genes, 234 of which did not have an assigned
chromosomal location. The gene density plots of each chromosome are in Figure 2.38.
There were no gene-dense regions found on any of the chromosomes from this set.
Since this set was extremely large, clustering was performed using the HOPACH
algorithm. There was only one variable available for clustering with this set, which was
the variance ratio for each significant gene in the strain. From this data, the HOPACH
algorithm identified 2 main clusters in the 1st level of the tree, with a median split
silhouette of -0.16666667. Figure 2.37 shows the ordered distance matrix of the genes in
this set. There are no major trends of clusters not correlating with each other – it appears
that almost all of the clusters have a positive correlation with one another. Figure 2.37
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Figure 2.34: Ordered distance matrix and bootstrap reappearance proportions of
genes that had a significant variance ratio in one and only one strain in the spleen
control group.
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Figure 2.35: Ordered distance matrix and bootstrap reappearance proportions of
genes that had a significant variance ratio in one and only one strain in the skin
treatment group.
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Figure 2.36: Gene density plots of genes that have a significant variance ratio in one and only one strain in the skin
treatment group.
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Figure 2.37: Ordered distance matrix and bootstrap reappearance proportions of
genes that had a significant variance ratio in one and only one strain in the spleen
treatment group.
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Figure 2.38: Gene density plots of genes that have a significant variance ratio in one and only one strain in the spleen
treatment group.
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also shows the barplot of the bootstrap reappearance proportions. From this plot, all of
the genes belong entirely to the same cluster, so bootstrap had no effect on the data.
Since both of the clusters found by HOPACH had more than 10 genes in them, no
new clusters needed to be created. There were 381genes in this set that were not
annotated with Gene Ontology terms. One GO term was found to be enriched in this set:
transcription factor complex (cellular components).
16. Genes that were significantly differentially expressed between the control and
treatment groups in one and only one strain in the skin group. There were 1,857 genes in
this set, 284 of which did not have a Gene ID. This reduced the set to 1,573 genes, 372
of which did not have an assigned chromosomal location. The gene density plots of each
chromosome are in Figure 2.40. There were no gene-dense regions found on any of the
chromosomes from this set.
Since this set was extremely large, clustering was performed using the HOPACH
algorithm. There was only one variable available for clustering with this set, which was
the t-test value for each significant gene in the strain. From this data, the HOPACH
algorithm identified 2 main clusters in the 1st level of the tree, with a median split
silhouette of -1.000. Figure 2.39 shows the ordered distance matrix of the genes in this
set, which shows that the two levels of the tree don’t correlate with each. Figure 2.39
also shows the barplot of the bootstrap reappearance proportions. From this plot, all of
the genes belong entirely to only one of the two clusters.
Since both of the clusters found by HOPACH had more than 10 genes in them, no
new clusters needed to be created. There were 0 genes in this set that were not annotated
with Gene Ontology terms, and no terms were found to be enriched in either cluster.
17. Genes that were significantly differentially expressed between the control and
treatment groups in one and only one strain in the spleen group. There were 886 genes in
this set, 112 of which did not have a Gene ID. This reduced the set to 774 genes, 82 of
which did not have an assigned chromosomal location. The gene density plots of each
chromosome are in Figure 2.41. There was one gene-dense regions found on
chromosome 16. The region under the peak of the density curve for this chromosome
covered four megabases: from 0 to 40,000,000 bp. There were 20 genes from this set on
chromosome 16, 16 of which were underneath the peak in the curve. The genes under the
curve were: periplakin, ataxin 2 binding protein 1, protamine 2, G1 to phase transition 1,
snail homolog 2 (Drosophila), RIKEN cDNA 4933404G15 gene, stromal cell-derived
factor 2-like 1, synaptosomal-associated protein, DiGeorge syndrome critical region gene
6, DiGeorge syndrome critical region gene 8, polymerase (RNA) II (DNA directed)
polypeptide H, histidine-rich glycoprotein, mucin 4, ribosomal protein L35a, zinc finger
protein 148 and RIKEN cDNA 2010005H15 gene. These genes had start sites of
4575804, 6566524, 10362916, 10783139, 14243425, 16311915, 16760918, 17010508,
17657698, 17858887, 20341415, 22655909, 32447691, 32765514, 33113873 and
35866435 respectively. Only one of these genes was not annotated with a Gene
Ontology category, but the remaining 15 genes were not found to be enriched for any GO
categories.
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Figure 2.39: Ordered
red distance matrix and bootstrap reappearance proportions of
genes that were significantly differentially expressed between the control and
treatment groups in one and only one strain in the skin group.
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Figure 2.40: Gene density plots of genes that are significantly differentially expressed between the control and treatment
groups in one and only one strain in the skin group.
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Figure 2.41: Gene density plots of genes that are significantly differentially expressed between the control and treatment
groups in one and only one strain in the spleen group.
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Since this set was extremely large, clustering was done using the HOPACH
algorithm. There was only one variable available for clustering with this set, which was
the t-test value for each significant gene in the strain. From this data, the HOPACH
algorithm identified 2 main clusters in the 1st level of the tree, with a median split
silhouette of -1.000. Figure 2.42 shows the ordered distance matrix of the genes in this
set, which shows that the two levels of the tree don’t correlate with each. Figure 2.42
also shows the barplot of the bootstrap reappearance proportions. From this plot, all of
the genes belong entirely to only one of the two clusters.
Since both of the clusters found by HOPACH had more than 10 genes in them, no
new clusters needed to be created. There were 0 genes in this set that were not annotated
with Gene Ontology terms, and no terms were found to be enriched in either cluster.
18. Genes that were significantly differentially expressed between the treatment and
control group, and had a significant variance ratio in both the control and treatment
groups, in one and only one strain in the skin. There were 502 genes in this set, 42 of
which didn’t have a Gene ID. This reduced the set to 460 genes, 246 of which did not
have an assigned chromosomal location. The gene density plots of each chromosome are
in Figure 2.44. There was a region on chromosome 3 found to have a significant density
of genes on it. There were 8 genes from this set on chromosome 3, 7 of which are under
the peak in the density curve. The peak in the curve spans 2.5 megabases, and contains
the following genes: RIKEN cDNA 6330415M09 gene, farnesyl diphosphate synthetase,
RIKEN cDNA 4932431F02 gene, RIKEN cDNA 4932431F02 gene, RIKEN cDNA
1110058A15 gene, RIKEN cDNA 2310007A19 gene and RIKEN cDNA 2610022K04
gene. These genes had start sites of 88863530, 91299735, 92413789, 92413789,
95637164, 97162792 and 97835296 respectively. Four of these genes were not annotated
with a Gene Ontology term, and there were no terms found to be enriched in the
remaining 3 genes.
Since this set was so large, clustering was performed using the HOPACH
algorithm. There were three variables used for clustering: the t-test value, the variance
ratio for the control group and the variance ratio for the treatment group. From this data,
the HOPACH algorithm identified 117 main clusters in the 5th level of the tree, with a
median split silhouette of 0.2781948. Figure 2.43 shows the ordered distance matrix of
the genes in this set. There are surprisingly few clusters that positively correlate with one
another, as most of the clusters have no correlation with each other, as indicated by the
yellow color. Figure 2.43 also shows the barplot of the bootstrap reappearance
proportions. Many of the genes belong to the first HOPACH cluster. Most of the genes
belong to 5 different clusters, and none belong exclusively to one cluster. Almost all of
the genes have equal bootstrap reappearance proportions in each cluster to which they
belong, which is something not present in most of the other sets.
Since there were so many clusters derived by HOPACH, clusters with less than 10
genes in them were combined into clusters of 20 or more genes, as described in the
Methods section. This yielded 68 clusters that had at least 10 genes each in them. From
this set, there were 258 genes that did not have Gene Ontology annotations. Each cluster
was analyzed for enriched terms, as described in the Methods section, but no terms were
found to be enriched in this set.
The above results are summarized in Table 2.7 as well.
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Figure 2.42: Ordered distance matrix and bootstrap reappearance proportions of genes that
were significantly differentially expressed between the control and treatment groups in one
and only one strain in the spleen group.
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Figure 2.43: Orderedd distance matrix and bootstrap reappearance proportions of
genes that were significantly differentially expressed between the control and
treatment groups, and had a significant variance ratio in both the control and
treatment groups in one and only one strain in the skin.
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Figure 2.44: Gene density plots of genes significantly differentially expressed between the treatment and control group, and
had a significant variance ratio in both the control and treatment groups, in one and only one strain in the skin.
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Table 2.7: Summary of results from the analysis of different sets of genes.
Gene Set
Significant variance ratio in all 6 strains in the
skin control group
Significant variance ratio in 5 strains in the
spleen control group
Significant variance ratio in 5 strains in the skin
treatment group
Significant variance ratio in 5 strains in the
spleen treatment group
Significant variance between the strains but not
within in the skin treatment group
Significant variance between the strains but not
within in the spleen treatment group
Significant variance ratio in the treatment group,
but not the control group, in 5 of the strains in
the skin tissue
Significant variance ratio in the treatment group,
but not the control group, in 5 strains in the
spleen tissue
Significant variance ratio in the control and
treatment groups, and differential expression
between these groups in the skin tissue
Differentially expressed between the control and
treatment groups in all 6 strains in the skin
tissue
Differentially expressed between the control and
treatment groups in all 6 strains in the spleen
tissue
Significant variance ratio in only one strain in
the skin control group
Significant variance ratio in only one strain in
the spleen control group
Significant variance ratio in only one strain in
the skin treatment group
Significant variance ratio in only one strain in
the spleen treatment group
Differentially expressed between the control and
treatment groups in only one strain in the skin
treatment group
Differentially expressed between the control and
treatment groups in only one strain in the spleen
treatment group
Differentially expressed between the treatment
and control group, and significant variance ratio
in both the control and treatment groups in only
one strain in the skin

Enriched
Chromosome
None

Enriched GO Terms

None

None

None

None

None

None

None

None

None

None

None

Male sex differentiation, integrinmediated signaling pathway, external
side of plasma membrane and cell
surface
None

None

None

Chromosome
3: 2.5 Mb
Chromosome
11: 5 Mb
None

None

None

None

None

None

None

None

None

None

None

None

None

None

Chromosome
16: 4 Mb

None

Chromosome
3: 2.5 Mb

None

Molecular function unknown
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Gene sets with too few genes to analyze:
The following sets of genes did not have enough genes in them to perform any type of
quantitative analysis for the reasons given:
1. Genes with a significant variance ratio and were differentially expressed between
strains in the skin control. There were 7 genes in the set, none of which had a Gene ID.
2. Genes with a significant variance ratio and were differentially expressed between
strains in the spleen control. There were 0 genes in the set.
3. Genes with a significant variance ratio and were differentially expressed between
strains in the skin treatment group. There were 0 genes in the set.
4. Genes with a significant variance ratio and were differentially expressed between
strains in the spleen treatment group. There were 0 genes in the set.
5. Genes with a significant variance ratio in the control and treatment groups, and was
differentially expressed between these groups in the spleen tissue. There were 0 genes in
the set.
6. Genes that were significantly differentially expressed between the treatment and
control group, and had a significant variance ratio in both the control and treatment
groups, in one and only one strain in the spleen. There were 0 genes in this set.
Pooled Data:
The same tests were applied to this second data set, as was applied to the above
data. The data was normalized using the procedure described in the Methods section,
where the treatment group was the cDNA samples that came from a pool, and the control
group was the cDNA samples that came from a single animal.
There were hundreds of genes found to be differentially expressed (FDR p < .001)
between the single-animal and pooled groups in the skin tissue (Figure 2.45). There was
only data from a single strain available in the spleen tissue, and almost no genes were
found to be differentially expressed. Because of this, variance ratios could only be
calculated in the skin tissue. As shown in Figure 2.46, there was a large increase in the
number of genes with a significant variance ratio (p < .01) in the pooled-animal group as
opposed to the single-animal group. The same basic trends are seen with this data, as
with the above data set when comparing the REMLbetween and REMLwithin estimates
(Figures 2.47 and 2.48). The single-animal group had much smaller REMLbetween and
REMLwithin estimates than did the pooled group. As before, there were some extreme
outliers in Figure 2.48, and these were removed from the plot.
Figures 2.49 and 2.50 show the gene density plots with the genes that have a large
variance estimate within a strain, but not between.
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Figure 2.45: The number of significantly differentially expressed genes
between the single and pooled samples of RNA in each tissue and strain.
The spleen tissue had only the B6.C, so B6/J and C3H. can be ignored.
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Figure 2.46: Number of genes in each strain with a statistically significant variance ratio (p < .05).
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Figure 2.47: REML estimate between strains vs. within strain for the single-animal RNA. Red points represent
skin.
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Figure 2.48: REML estimate between strains vs. within strain for the pooled RNA. Red points represent skin. Several
extreme outliers were removed from this plot.
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Figure 2.49: Gene density plots of genes with a significant variance ratio within the strains, but not between
in the skin treatment.
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Figure 2.50: Gene density plots of genes with a significant variance ratio within the strains, but not between
in the spleen treatment.
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V. Discussion
The primary focus of this study was to identify inter-individual differences in
mice, in response to low-dose radiation treatment. On the whole, radiation treatment had
a dramatic effect on a mouse’s gene expression, both in terms of variability and differing
expression. In both tissues and every strain, there was an increase in the number of genes
that had a significant variance ratio. The radiation treatment also appears to have had a
more dramatic effect on the skin tissue, than the spleen tissue, as there are many more
genes with a significant variance ratio. The estimates for the between- and within-strain
variance were also dramatically larger in the treatment group, as compared to the control.
This is evident by the scales of the plots in Figures 2.4 and 2.5. It is possible that such
large variances were obtained in the treatment group because the sample size was too
small [95]. The trends in these plots are of interest as well, in that Figure 2.4 has points
in both tissues where there is an increasing amount of between-strain variance with very
little within-strain variance. This then winds into a linear trend between the two
variables, but very few points are present with a large within-strain variance and small
between-strain variance. This is not the case in Figure 2.5 though, where there are still
these same two trends, but also a large number of genes that have a large within-strain
variance but small between-strain variance. This shows that animals with the same
genetic background respond differently to the radiation treatment. Since these animals
have the same genetic constitution, the only factor that could be contributing to these
differences in gene expression could be environmental influences. Such factors could
include litter size, the number of male versus female pups in a litter, or the age of the
mom. The large between-strain variance is due to the fact that inbred strains are known
to differ slightly genetically due to the presence of single nucleotide polymorphisms
(SNPs). It has been shown that in inbred mice strains, there are blocks of SNPs in genes
located throughout the genome [33], which can easily lend to the variation in gene
expression noticed here. Because of this, identifying the chromosomal location of highly
variable genes is of interest. As shown in Figures 2.49 and 2.50 though, genes with a
large within-strain variance but small between-strain variance don’t have any gene-dense
clusters on any of the chromosomes in either the skin or spleen tissue. It would be
expected that if blocks of SNPs were playing an important role in the animal’s response
to radiation, that there would be genes with a large variance clustered together in the
genome.
In addition to empirically looking at the differences between the control and
treatment groups by assessing differences in the variance ratio, multiple pair-wise
comparisons were made between these groups. Even with a false discovery rate (FDR)
correction, many genes were found to be differentially expressed in both tissues and all
strains. As with the variance ratios, the skin had a larger number of significant genes
than did the spleen tissue. The B6.C and Bl6Jx strains had almost twice as many genes
differentially expressed than any of the other strains in the skin tissue. They had also had
many more genes with a significant variance ratio in the skin treatment group, although
there wasn’t as large of a disparity between these and the other strains. There was no
different between these two strains and the other four strains in the spleen tissue with
either test though.

93
Another test for differential expression was also done between the different
strains in each tissue and treatment type. This attempted to assess inter-strain differences
in the means of the residuals of the expression values. No multiple comparison
adjustment was made with this test, since so few genes were found to be significant.
While more genes were found to be differentially expressed in the control group
compared to the treatment group, the numbers are so small that this cannot be interpreted
as being significant. Therefore, it can be assumed that in comparison of the means of the
strains, there are no significant differences in expression.
Since this study was focused around the characterization of inter-individual
differences in low-dose radiation exposure response, it was important to know interindividual similarities as well. This was accomplished by identifying genes that were
variable and differentially expressed in more than one strain. These genes would be
expected to be involved in typical response pathways, such as DNA damage response, or
common “housekeeping” pathways, such as the cell cycle. Surprisingly though, as
shown in Table 2.3, there are no genes in the either tissue of the treatment group that
have a significant variance ratio in all six strains. There are many genes common to 5 of
the 6 strains in both tissues, and many more in the treatment groups than in the control
groups. It is expected that in the control groups there are few genes with a significant
variance ratio in most of the strains, since common housekeeping genes are not expected
to have dramatic differences in their expression levels. There are 10 genes in the skin
control group that have a significant variance ratio in all 6 strains though. It would be
expected that there would be genes with a significant variance ratio in the treatment
groups though, as all mice have the same pathways, and it would be expected that the
pathways relevant to radiation response would be activated as a result of the radiation
exposure, which would increase variability of expression of the constituent genes. This
however, was not the case. If anything this again points to inter-individual differences in
response to low-dose radiation treatment.
A similar approach was taken to identify genes with a significant variance ratio in
both tissues and between different strains. It would be expected that both the skin and
spleen tissues might have some common functions in response to radiation exposure, so
would have some of the same genes being actively transcribed. Interestingly enough
though, there were no genes with a significant variance ratio in both tissues that were
common to even 5 of the 6 strains. This was also true in the controls. There were some
genes in the treatment group that were common between 4 of the 6 strains, as shown in
Table 2.4.
This same interest was pursued with genes found to be differentially expressed
between strains, although since so few genes were found to be significant, no conclusions
can be drawn from this. In the test of differential expression between control and
treatment groups, many genes were found to be significant in all of the inbred strains.
There were 1,563 genes in the skin tissue, and 654 genes in the spleen tissue that were
differentially expressed in all six strains. It is possible that many of these genes are
involved in cellular responses to radiation treatment, or associated pathways.
A related critical question to consider was how many of these genes that were
significantly variable or differentially expressed were significant in one and only one
strain? Many genes were found to have a significant variance ratio in only one strain, as
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shown in Figure 2.9. As before, there are more variable genes in the treatment group
than the control, although BALBxJ in the skin, and B6.C and Bl6Jx in the spleen have
almost the same number of genes in the treatment as the control. This is interesting, since
it was these last two strains that had so many more genes differentially expressed in the
skin between the control and treatment groups. These two strains seem to have this same
effect (as do others) in the skin tissue, where there are more than twice as many genes
variable between the control and treatment groups, but it is interesting that there are such
dramatic differences in the two tissues. One possible interpretation of this is that the
differing genetic backgrounds of the inbred strains are not contributing to the animal’s
response to radiation in the spleen tissue, but it is having considerable effects in the skin
tissue.
Genes that were differentially expressed between the treatment and control groups
were also analyzed for how many were significant in one and only one strain. B6.C had a
considerable number of genes that were differentially expressed in the skin, which was
more than four times as many genes as any of the other strains. The spleen tissue in each
strain had a small number of genes differentially expressed in only one strain, with the
exception of A/J, which had almost the same number of genes in both tissues. On the
whole though, most of the strains did not have very many genes that were significantly
differentially expressed in only one strain.
Another comparison identified how many genes were differentially expressed
between the treatment and control groups in only one strain, and how many of these also
had a significant variance ratio. Surprisingly, there were no genes in any of the strains in
the spleen tissue that were both differentially expressed and variable in only one strain.
In the skin tissue, B6.C and Bl6Jx had more than two hundred genes each (283 and 241
respectively), while the other four strains each had less than thirty. Since there are such a
small number of genes with overlap between these two tests, it is possible that many
genes are simply a statistical artifact, and not biologically meaningful. This could very
well be the case with genes that have a large variance ratio, but are not differentially
expressed. On the other hand, genes with a high variance ratio and differential
expression are ones with only a few individuals changing expression, but apparently have
a large enough change to yield a significant amount of differential expression.
Since these tests revealed some similarities between the strains, hierarchical
clustering was performed on the arrays, to attempt to flush out any relationships between
the strains. As shown in Figure 2.12, the strains do not seem to cluster together, and
there don’t appear to be any consistent relationships between them. The patterns and
distances (Euclidean distances were used) are not similar between the skin and spleen in
either the control or treatment groups. In Figure 2.13, the replicate arrays within a strain
were averaged, and clustering was again performed. It was expected that there would be
some consistent patterns of clustering between the strains, but this again was not the case.
None of the strains cluster together in the same pattern between tissues or treatment
groups. This could be affected by how many genes are variable in their expression, and
the fact that most of these variable genes are different between the two tissues.
While taking an empirical view of the results of the different statistical tests
performed is informative, it is also of interest to find biological significance in the genes
identified. Since little is known about specific radiation exposure-related responses, and
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how these change between individuals with differing genetic constitutions, it is of
particular interest to identify genes that could potentially be involved in related pathways.
There were two basic mechanisms for doing this: to look at regions of the chromosomes
that had a disproportionate number of genes located near each other, and to identify any
Gene Ontology categories that were enriched. There were 23 different sets produced,
each of which is described in the Results section. Sets with more than 30 genes were
clustered, to attempt to produce smaller groups of related genes. In this way, it would be
more likely to identify groups enriched for Gene Ontology categories. Clustering
appeared to have a positive effect on all of these sets, except for those for which
clustering was performed on a single value (sets with genes unique to a single strain). In
these sets, clustering only found two groups in each set, and little significance could be
drawn from this.
Each cluster of each set was analyzed for enriched Gene Ontology categories,
although disappointingly few were found. There were three enriched categories found in
the genes that had a significant variance ratio in 5 of the 6 strains in the skin treatment
group. These were: cytokine and chemokine-mediated signaling pathway, heparin
binding and integrin-mediated signaling pathway. Each of these three categories had
three genes each in them. Cytokine and chemokine-mediated signaling pathway was
comprised of protein tyrosine phosphatase non-receptor type 6, Kruppel-like factor 6, and
kit oncogene. The heparin binding category contained laminin gamma 2, serine (or
cysteine) proteinase inhibitor, clade D, member 1 and cysteine rich protein 61. The third
term, integrin-mediated signaling pathway contained integrin alpha 2, PTK2 protein
tyrosine kinase 2 and a disintegrin and metalloprotease domain 22. In the set of genes
that had a significant variance ration in 5 of the 6 strains in the treatment but not control
groups in the skin tissue, and four terms were found to be enriched: male sex
differentiation, integrin-mediated signaling pathway, external side of plasma membrane
and cell surface. Each of these four categories also only had three terms in each of them.
Male sex differentiation had androgen receptor, bone morphogenetic protein receptor,
type 1A and platelet derived growth factor receptor, alpha polypeptide. Integrinmediated signaling pathway had the same terms as listed before, and external side of
plasma membrane contained thymus cell antigen 1, theta, CD200 receptor 1 and EGFlike module containing, mucin-like, hormone receptor-like sequence 1. The fourth term,
cell surface contained the same genes as external side of plasma membrane. One term
was enriched in the set of genes that were differentially expressed between the control
and treatment groups in all six strains, but this term was molecular function unknown,
which is not at all helpful. Seven genes from the set were listed in this category: RIKEN
cDNA 5730494M16 gene, dynein 2 light intermediate chain, CDK5 regulatory subunit
associated protein 3, ubiquilin 4, BCRABL transformation potentiating sequence, RIKEN
cDNA 2810429O05 gene and excision repaiross-complementing rodent repair deficiency,
complementation group 8. There was also one term found in the set of genes that had a
significant variance ratio in only one strain in the spleen treatment group. This was
surprising, given the fact that clustering of this set was ineffective. The enriched term
found was transcription factor complex. 74 genes from the set were annotated with this
term, and are too many to list here.
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In addition to the identification of enriched Gene Ontology categories, each of
the 17 sets large enough to be analyzed was plotted in gene density distributions along
the chromosomes. A background distribution was created from the genome, and each set
was used to create a second distribution, as described in the Methods section. In the set
of genes that were differentially expressed between the control and treatment groups, and
were also variable in both groups in the skin tissue, there were regions of interest
identified on chromosomes 3 and 11. There were 12 genes from this set located on
chromosome 3, 9 of which were under the peak in the density curve. Chromosome 11
had 22 genes from the set on it, 12 of which were underneath the peak in the density
curve. Chromosome 16 was also found to have a gene-dense region in the set of genes
that were significantly differentially expressed between the control and treatment groups
in one and only one strain in the spleen tissue. There were 20 genes in this set located on
chromosome 16, 16 of which were under the peak of the density curve. There was also a
region of interest found on Chromosome 3 in the set of genes that were differentially
expressed between the control and treatment groups, and had a significant variance ratio
in both groups, in only one strain in the skin tissue. Eight genes from this set were found
on chromosome 3, 7 of which were located under the peak of the density curve. Each of
these regions was tested for enriched Gene Ontology categories, although none were
found. The specific genes in each of these groups just mentioned are detailed in the
Results section. There does not seem to be any obvious relationships between the genes
in these dense regions, especially since most of these are Riken clones, for which there
are few details available.
The final part of this study consisted of assessing changes in the variability of
gene expression in samples that came from a single animal, and those that came from a
pool of four animals. There was a large increase in the number of genes found to have a
significant variance ratio in the skin tissue in the single animal samples compared to the
pools. This increase wasn’t as dramatic in the B6/J strain as it was in the B6.C and C3H
strains, but there was still a large increase in the number of variable genes. The same
trends were noticed in the relationship of between- and within-strain variances as in the
low-dose study. In the single animal plot (Figure 2.47), genes had the same trend as the
control group in the radiation study (Figure 2.4), where there were no genes with a large
within-strain variance and small between-strain variance. In the plot of samples from the
four-animal pools (Figure 2.48) though, this trend changes to look more like Figure 2.5
(radiation treatment). There are many genes that have an increasing within-strain
variation and small between-strain variance. This clearly shows that by using a tissue
sample for a microarray hybridization that comes from a pool of animals, variability is
being added into the experiment, which cannot be accounted for through statistical
adjustment. In addition, several hundred genes were also found to be differentially
expressed between the single animal and pooled samples (Figure 2.45), which may be
statistical artifacts.
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Chapter 3
Bayesian network analysis
I. Abstract
Pathway analysis and network construction methods have become a popular topic
of interest in the bioinformatics community, which has been a result of the large volumes
of data being produced through high-throughput genomics experiments. One popular
method for building such pathways are through the use of Bayesian networks. Many
questions remain unresolved in their application though, such as how many experiments
are required before an accurate model can be produced, and how accurate is that model.
Based upon the simulations run, a minimum of 300 data points is required to obtain a
graph that resembles the true structure, while more than 300 data points continues to
improve the accuracy. The same number of data points also consistently produced the
highest scoring graph, and allowed for the identification of modules within the graphs.
The accuracy of this decreased though as the size of the graphs increased. Therefore, in
consideration of applying such a method to the biological domain, a minimum of 300
experiments should be included before attempting to build a small network.
II. Introduction
Since the human and mouse genome sequencing projects were completed, and
advances in high throughput analytical technologies for assessing gene expression, there
have been tremendous amounts of data produced on a vast array of topics. Because of
this, new computational challenges are to make sense out of this overwhelming amount
of experimental data. Of particular interest in this field though, is how to group genes
with similar gene expression profiles together, and how to use this information to predict
connections between genes to form a genetic network. One of the most interesting types
of networks studied in this way are regulatory networks, which determine the cascade of
events that must occur to initiate a metabolic process. Such networks would require
directional connections between nodes, as well as many data points taken over a period of
time. While this is a challenging, and as of yet unattainable task, it is currently the goal
of many researchers to develop and apply these techniques within the context of genetics.
There are many different types of networks that can be created using gene
expression data. The simplest of which is a correlation graph, where a Pearson or
Spearman correlation coefficient is calculated for all pairs of genes on the array, and any
coefficients above some threshold value are assumed to have an edge between them.
From a biological standpoint though, this is too simplistic of a measure. It is only a pairwise comparison between genes, which cannot account for multiple interactions among
genes or non-linear relationships. As such, other methods have recently become popular
in working with such data sets.
A popular algorithm for inferring underlying networks involves the application of
Bayes theorem, and is known as a Bayesian Network. Such networks have been built
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from biological data, and have been shown to be reliable and accurate [55, 56, 65, 96].
In their simplest sense, Bayesian networks provide a sophisticated measure of association
between genes. They require both a prior and some new data, to calculate a posterior
distribution. Algorithms for the construction of Bayesian networks are computationally
intensive and rely on heuristic methods. Many different heuristics have been attempted,
such as the K2 algorithm, Markov-Chain Monte Carlo methods and genetic algorithms.
One possible way to circumvent the computational complexity of Bayesian
methods would be to identify groups of genes associated with a particular function from a
larger set. Methods to do this, such as those used in Chapter 2 would be ideal. However,
as we demonstrate, a large number of data points are required to learn the structure of a
Bayesian network. Therefore the data set studied in Chapter 2 could not be utilized in
this chapter. Instead, data was simulated, so that a known structure was available to use
as a reference to test the accuracy of the structure learning methods.
III. Methods
Bayes Net Toolkit:
The Bayes Net Toolkit (BNT)[69] is an open-source toolbox for the development
of directed graphical models for use in Matlab. The toolkit has methods that support
many different types of conditional probability distributions, exact and approximate
inference, parameter and structure learning, and static and dynamic models [69]. Of
particular interest in this application are the functions supporting structure learning. The
BNT has the ability for exhaustive search, which enumerates all possible graphs. There
were three computers used in computing the graphical models in this section. The first
two are sun4u Sun Fire 880 machines running sunOS 5.9 with four 900 Mhz processors
and 8192 Megabytes of RAM. The third is a sun4u Sun Blade 100 (UltraSPARC-IIe)
running sunOS 5.9 with one 502 Mhz processor and 512 Megabytes of RAM. The first
two machines have Matlab Version 6.5.0.180913a Release 13, and the third has Matlab
Version 7.0.1.24704 (R14) Service Pack 1 available. Given the aforementioned hardware
platforms, it was not possible to enumerate through exact methods all possible graphs on
a set with more than three nodes. Therefore, approximation methods were used. There
are several available in the BNT: the K2 algorithm, Hill-climbing and the MetropolisHastings algorithm, which is a type of Markov-Chain Monte Carlo (MCMC) algorithm.
All results obtained in this chapter were performed using the MCMC method, as it
proved to give more accurate results (data not shown). The MCMC algorithm
implemented in the BNT only allows a directed acyclic graph to be computed, and uses
the acyclicity check described by Giudici et. al. [97].
Topology Simulation:
The topology of a graph describes the connection between its nodes along with
the direction of the connection. The topology simulation entailed assessing the accuracy
of the MCMC algorithm in learning the entire structure of the graph. A graph was first
simulated from a power-law distribution [98, 99], as biological networks have been
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shown to exhibit scale-free properties [100, 101]. The topology of scale-free networks
is dominated by several highly connected hubs, or nodes with the largest degree [102].
The degree of each node in the graph was simulated by inverting a power law probability
density:
(β * µi) -1/λ
Number of Nodes = ----------------2

Formula 3.1

where β controls the y-intercept of the log-log plot, µI is a random number from the
continuous uniform distribution (Matlab unifrnd() function), and λ controls the number of
edges in the graph [99]. After the degree of each node was calculated, edges were
randomly added into the graph, until the desired degree of each node was reached. While
most graphs consider the in-degree and out-degree to be separate entities, the degree here
is the combination of the two. Each node takes only binary values indicating an on or
active state and an off state. This approximation was considered so that as increasing the
number of discrete levels possible for each node would have greatly increased the amount
of data required to learn the graph [71].
Once the graph is simulated, parameters had to be created. This consisted of
creating a conditional probability table for each node, which is done by sampling from
the dirichlet distribution. Such a table dictates the probability that the child node has any
possible value for all combinations of all possible values of the parent nodes [79]. The
random number generator was seeded with three different integers for each of the three
iterations: 1357901, 2930135 and 7012567. A tabular conditional probability table was
used for each node, and from these tables, sample data was created. This was done using
the BNT function sample_bnet.
Once data was simulated, the BNT’s learn_struct_mcmc() function was used to
search over the possible directed acyclic graphs. Each time this algorithm was run,
10,000 samples were taken from the possible search space, after 600 graphs were
sampled (the burnin). The accept/reject ratio was returned from each of the sampled
graphs. This was plotted for each simulation, a sample of which appears in Figure 3.1.
Each of the 10,000 sampled graphs were then scored using the Bayesian
Information Criteria (BIC) scoring metric[66]. In the BNT, BIC is calculated as follows:
log P(D | theta_hat) - 0.5*d*log(N)

Formula 3.2

where D is the data, theta_hat is the maximum likelihood estimate of the parameters, d is
the number of parameters, and N is the number of data cases. The BIC method has the
advantage of not requiring a prior. The graph with the maximal score was kept, although
it is recognized there may be multiple graphs with an equal score. Conditional
probability tables were learned from the data for the highest scoring graph using the
learn_params function, which attempts to find the maximum likelihood parameters for a
fully observed model. Several different metrics were used to assess the quality of the
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Figure 3.1: Sample plot of MCMC accept/reject ratio.
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learned model versus the original model. The first four are just measures of the
differences of edges in the learned graph versus the original graph. These are: true
positives, true negatives, false positives and false negatives. From these four measures,
there are several other metrics that can be calculated, as described in Schafer et. al. [103].
These are defined in Table 3.1. The final measurement made was to count the number of
empty rows in the conditional probability tables for each node in the learned graph. This
was considered to be another indicator of how much data was required to confidently
learn the graph topology.
The topology simulation was setup to measure how much data was required to
accurately learn the topology of a graph of size n. Four different graph sizes were used:
5, 8, 10 and 25 nodes. Graphs were created using a power-law distribution, as mentioned
above, with beta set to 7.0 and lambda set to 7.5. Plots of the degree of nodes were
created, to compare the distribution of the original graph to that of the highest scoring
learned graph, one of which is shown in Figure 3.2. For each graph size, the simulation
was run three times, using 2, 4, 6, 8, 10, 25, 50, 75, 100, 300, 500, 700, 900 and 1500
data points. The metrics described above were measured in each iteration, and the three
measurements for each node size and number of data points were averaged.

Table 3. 1: Definition of metrics used for assessing accuracy of the
topological structure of a learned graph.
Quantity
Number of true edges
Number of zero-edges
Significant edges
False positive rate
False negative rate
True negative rate (specificity)
True positive rate (sensitivity, power)
Positive predictive value
False discovery rate

Definition
TP + FN = ηAE
TN + FP = ηOE
TP + FP = S
E(FP/( ηOE)) = α1
E(FN/( ηAE)) = α11
1- α1
1- α11
PPV = E(TP/S|S > 0)
FDR = E(FP/S|S > 0)
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Figure 3.2: Sample plot of the node degree distribution of the original and
learned graphs.

Features Simulation:
The features simulation entailed finding edges within high-scoring sampled
graphs that were consistently present. In this simulation, a graph was generated, as
described in the topology simulation section (above), as were conditional probability
tables and sample data. 10,000 graphs were sampled with a burnin of 600 using the
MCMC algorithm in the BNT. Each of the sampled graphs was scored using the BIC
metric, and these were subsequently sorted. The scores from the returned samples were
plotted, are shown in Figure 3.3. As with the topology simulation, there were 4 different
sizes of graphs used: 5, 8, 10 and 25 nodes. There were seven different sizes of data
points used: 100, 300, 500, 700, 900, 1500 and 5000. Each of the four graphs was
generated using the aforementioned number of data points five times. The seeds for the
random number generator are as follows: 1357901, 2930135, 7012567, 8225410 and
5552431.
Once the scores from the sampled graphs were sorted, those graphs with a score
within 3 of the highest scoring graph were retained. A matrix was then created from
these, where the cells represented the proportion of graphs within this sample that contain
an edge. Since this was done five times, these were averaged to create a final “features”
matrix. Any edges that were present in 60% of the graphs or more were retained, and
those were used to create a graph. The features graphs, and original graphs were then
visualized in ALIVE and compared.
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Figure 3.3: Example histogram of BIC scores from the features simulation.
Scores were binned into groups of 3.
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ALIVE:
Applet for Looking at Vertices and Edges (ALIVE) is an interactive graph
visualization tool for multidimensional views of biological networks developed by Xinxia
Peng and Adam Tebbe. It allows for the interactive isolation of small subgraphs with a
large network in various ways, so as to allow users to focus on defined regions of interest.
Additionally, it allows for multidimensional relationships between nodes to be identified,
using node and edge coloring. A node or edge can be labeled with multiple values, so
that attributes in common between nodes can be visually identified. ALIVE has several
useful features for graph manipulation, but also allows the user to build the graph from a
single node, or “walk” through the graph, by selecting the next node of interest to add to
the graph. A screenshot of ALIVE is shown in Figure 3.4, The nodes are labeled with
the gene names, and are colored according their classification as listed on BioCarta's
website. The edges are labeled with the interaction classification also listed on BioCarta's
website. They are colored according to their labels (although could be colored by a
different label, again allowing for multidimensional data to be viewed in a
complementary fashion). Also shown is the node information for BCAR1. This shows all
of the labels for the node, in addition to all of its neighbors (which in this case is only
PTK2).

Figure 3. 4: Screenshot of ALIVE’s interface.
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IV. Results
Topology Simulation
The following four tables display the different metrics of accuracy of the MarkovChain Monte Carlo algorithm in the Bayes Net Toolkit. Table 3.2 contains the results
from a graph containing 5 nodes, with the number of simulated data points ranging from
2 to 5000. Tables 3.3, 3.4 and 3.5 display these same results for graphs with 8, 10 and 25
nodes respectively. Figures 3.5, 3.6, 3.7 and 3.8 contain plots of these different results,
for a visual interpretation of these results.
Features Simulations
Table 3.7 displays the results of the 5 runs for each level of data points in the
features simulation of a graph with 5 nodes. Increasing the number of data points used
did not have a positive effect on the highest scoring graph, or number of graphs that were
within 3 of the highest scoring graph. The seed for each of the 5 runs was different,
although with each number of data points in the simulated data, the same seeds were used
to initialize the random number generator. In Table 3.6, the average features matrix is
created by averaging the number of graphs with any given edge. Table 3.6 was created
from the graphs sampled with 5000 points of simulated data. The number of graphs used
to create the matrix was 18,233. Figure 3.9 displays the structure of the original graph on
the right (green), and the graph with edges present in 60% or more of the sampled graphs
on the left (red).
Table 3.9 displays the results of the 5 runs for each level of data points in the
features simulation of a graph with 8 nodes. Increasing the number of data points beyond
300 did not seem to have a positive effect on the highest scoring graph, or the number of
graphs that were within 3 of the highest scoring graph. The seed for each of the 5 runs
was different, although with each number of data points in the simulated data, the same
seeds were used to initialize the random number generator. In Table 3.8, the average
features matrix is created by averaging the number of graphs with any given edge. Table
3.8 was created from the graphs sampled with 5000 data points of simulated data. The
number of graphs used to create the matrix was 177. Figure 3.10 displays the original
graph on the right (green), and the graph with edges appearing in 60% or more of the
sampled graphs on the left (red).
Table 3.11 displays the results of the 5 runs for each level of data points in
the features simulation of a graph with 10 nodes. Increasing the number of data points
beyond 300 did not seem to have a positive effect on the highest scoring graph, or the
number of graphs that were within 3 of the highest scoring graph. The seed for each of
the 5 iterations was different, although with each number of data points in the simulated
data, the same seeds were used to initialize the random number generator. In Table 3.10,
the average features matrix is created by averaging the number of graphs with any given
edge. Table 3.10 was created from the graphs sampled with 5000 data points of
simulated data. The number of graphs used to create the matrix was 207. Figure 3.11
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Table 3.2: Metrics of accuracy for a graph with 5 nodes.
5 Nodes

2

4

6

8

10

25

50

75

100

300

500

700

900

1500

5000

True Positives

0.667

1.333

1.000

2.333

2.000

2.000

1.000

1.667

1.667

3.000

3.667

3.333

3.333

3.667

4.333

True Negatives

17.000

16.667

16.667

17.000

16.333

16.667

15.333

15.667

16.000

16.000

16.000

15.667

15.667

15.667

16.000

False Positives

1.000

1.333

1.333

1.000

1.667

1.333

2.667

2.333

2.000

2.000

2.000

2.333

2.333

2.333

2.000

False Negatives

6.333

5.667

6.000

4.667

5.000

5.000

6.000

5.333

5.333

4.000

3.333

3.667

3.667

3.333

2.667

Empty CPT Rows

3.000

1.667

2.000

1.000

0.667

0.333

0.333

0.333

0.333

0.333

0.000

0.000

0.333

0.000

0.000

True Edges

7.000

7.000

7.000

7.000

7.000

7.000

7.000

7.000

7.000

7.000

7.000

7.000

7.000

7.000

7.000

Zero Edges

18.000

18.000

18.000

18.000

18.000

18.000

18.000

18.000

18.000

18.000

18.000

18.000

18.000

18.000

18.000

Significant Edges

1.667

2.667

2.333

3.333

3.667

3.333

3.667

4.000

3.667

5.000

5.667

5.667

5.667

6.000

6.333

False Positive Rate

0.056

0.074

0.074

0.056

0.093

0.074

0.148

0.130

0.111

0.111

0.111

0.130

0.130

0.130

0.111

False Negative Rate

0.905

0.810

0.857

0.667

0.714

0.714

0.857

0.762

0.762

0.571

0.476

0.524

0.524

0.476

0.381

True Positive Rate

0.095

0.190

0.143

0.333

0.286

0.286

0.143

0.238

0.238

0.429

0.524

0.476

0.476

0.524

0.619

True Negative Rate

0.944

0.926

0.926

0.944

0.907

0.926

0.852

0.870

0.889

0.889

0.889

0.870

0.870

0.870

0.889

Positive Predictive Value

0.400

0.500

0.429

0.700

0.545

0.600

0.273

0.417

0.455

0.600

0.647

0.588

0.588

0.611

0.684

False Discovery Rate

0.600

0.500

0.571

0.300

0.455

0.400

0.727

0.583

0.545

0.400

0.353

0.412

0.412

0.389

0.316
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Table 3.3: Metrics of accuracy for a graph with 8 nodes.
8 Nodes

2

4

6

8

10

25

50

75

100

300

500

700

900

1500

5000

True Positives

1.667

1.333

2.000

3.667

2.333

3.667

4.000

4.000

3.667

6.333

7.333

7.667

6.333

8.000

8.000

True Negatives

45.000

44.000

45.333

46.000

45.667

46.000

45.000

45.000

44.000

46.000

46.333

46.667

45.333

46.667

45.667

False Positives

5.000

6.000

4.667

4.000

4.333

4.000

5.000

5.000

6.000

4.000

3.667

3.333

4.667

3.333

4.333

False Negatives

12.333

12.667

12.000

10.333

11.667

10.333

10.000

10.000

10.333

7.667

6.667

6.333

7.667

6.000

6.000

6.667

5.333

6.000

3.667

2.000

1.333

0.333

1.333

1.000

1.000

1.333

2.000

2.000

2.333

1.333

True Edges

14.000

14.000

14.000

14.000

14.000

14.000

14.000

14.000

14.000

14.000

14.000

14.000

14.000

14.000

14.000

Zero Edges

Empty CPT Rows

50.000

50.000

50.000

50.000

50.000

50.000

50.000

50.000

50.000

50.000

50.000

50.000

50.000

50.000

50.000

Significant Edges

6.667

7.333

6.667

7.667

6.667

7.667

9.000

9.000

9.667

10.333

11.000

11.000

11.000

11.333

12.333

False Positive Rate

0.100

0.120

0.093

0.080

0.087

0.080

0.100

0.100

0.120

0.080

0.073

0.067

0.093

0.067

0.087

False Negative Rate

0.881

0.905

0.857

0.738

0.833

0.738

0.714

0.714

0.738

0.548

0.476

0.452

0.548

0.429

0.429

True Positive Rate

0.119

0.095

0.143

0.262

0.167

0.262

0.286

0.286

0.262

0.452

0.524

0.548

0.452

0.571

0.571

True Negative Rate

0.900

0.880

0.907

0.920

0.913

0.920

0.900

0.900

0.880

0.920

0.927

0.933

0.907

0.933

0.913

Positive Predictive Value

0.250

0.182

0.300

0.478

0.350

0.478

0.444

0.444

0.379

0.613

0.667

0.697

0.576

0.706

0.649

False Discovery Rate

0.750

0.818

0.700

0.522

0.650

0.522

0.556

0.556

0.621

0.387

0.333

0.303

0.424

0.294

0.351
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Table 3.4: Metrics of accuracy for a graph with 10 nodes.
10 Nodes

2

4

6

8

10

25

50

75

100

300

500

700

900

1500

5000

True Positives

3.000

3.000

1.333

3.000

4.667

2.667

4.000

3.333

3.667

7.333

4.333

7.000

9.333

8.000

10.000

True Negatives

71.000

71.667

70.333

71.667

74.000

73.667

76.333

75.333

75.000

78.667

74.000

78.333

79.667

78.000

79.667

False Positives

12.000

11.333

12.667

11.333

9.000

9.333

6.667

7.667

8.000

4.333

9.000

4.667

3.333

5.000

3.333

False Negatives

14.000

14.000

15.667

14.000

12.333

14.333

13.000

13.667

13.333

9.667

12.667

10.000

7.667

9.000

7.000

Empty CPT Rows

20.000

21.000

13.000

14.000

8.000

4.333

2.667

4.667

4.000

4.667

3.000

3.333

0.667

2.333

3.000

True Edges

17.000

17.000

17.000

17.000

17.000

17.000

17.000

17.000

17.000

17.000

17.000

17.000

17.000

17.000

17.000

Zero Edges

83.000

83.000

83.000

83.000

83.000

83.000

83.000

83.000

83.000

83.000

83.000

83.000

83.000

83.000

83.000

Significant Edges

15.000

14.333

14.000

14.333

13.667

12.000

10.667

11.000

11.667

11.667

13.333

11.667

12.667

13.000

13.333

False Positive Rate

0.145

0.137

0.153

0.137

0.108

0.112

0.080

0.092

0.096

0.052

0.108

0.056

0.040

0.060

0.040

False Negative Rate

0.824

0.824

0.922

0.824

0.725

0.843

0.765

0.804

0.784

0.569

0.745

0.588

0.451

0.529

0.412

True Positive Rate

0.176

0.176

0.078

0.176

0.275

0.157

0.235

0.196

0.216

0.431

0.255

0.412

0.549

0.471

0.588

True Negative Rate

0.855

0.863

0.847

0.863

0.892

0.888

0.920

0.908

0.904

0.948

0.892

0.944

0.960

0.940

0.960

Positive Predictive Value

0.200

0.209

0.095

0.209

0.341

0.222

0.375

0.303

0.314

0.629

0.325

0.600

0.737

0.615

0.750

False Discovery Rate

0.800

0.791

0.905

0.791

0.659

0.778

0.625

0.697

0.686

0.371

0.675

0.400

0.263

0.385

0.250
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Table 3.5: Metrics of accuracy for a graph with 25 nodes.
25 Nodes

2

4

6

8

10

25

50

75

100

300

500

700

900

1500

5000

8.667

12.000

10.000

9.333

11.333

11.000

9.333

13.000

13.667

24.000

27.667

31.667

31.333

32.000

36.333

True Negatives

446.667

450.333

452.333

457.333

461.667

508.333

525.000

534.000

534.667

548.667

550.333

553.000

556.667

552.667

547.333

False Positives

127.333

123.667

121.667

116.667

112.333

65.667

49.000

40.000

39.333

25.333

23.667

21.000

17.333

21.333

26.667

False Negatives

42.333

39.000

41.000

41.667

39.667

40.000

41.667

38.000

37.333

27.000

23.333

19.333

19.667

19.000

14.667

6764.333

5386.000

4716.667

4095.333

4892.667

655.333

113.000

58.667

54.000

17.333

22.000

18.000

13.000

12.667

25.333

True Positives

Empty CPT Rows
True Edges

51.000

51.000

51.000

51.000

51.000

51.000

51.000

51.000

51.000

51.000

51.000

51.000

51.000

51.000

51.000

Zero Edges

574.000

574.000

574.000

574.000

574.000

574.000

574.000

574.000

574.000

574.000

574.000

574.000

574.000

574.000

574.000

Significant Edges

63.000

136.000

135.667

131.667

126.000

123.667

76.667

58.333

53.000

53.000

49.333

51.333

52.667

48.667

53.333

False Positive Rate

0.222

0.215

0.212

0.203

0.196

0.114

0.085

0.070

0.069

0.044

0.041

0.037

0.030

0.037

0.046

False Negative Rate

0.830

0.765

0.804

0.817

0.778

0.784

0.817

0.745

0.732

0.529

0.458

0.379

0.386

0.373

0.288

True Positive Rate

0.170

0.235

0.196

0.183

0.222

0.216

0.183

0.255

0.268

0.471

0.542

0.621

0.614

0.627

0.712

True Negative Rate

0.778

0.785

0.788

0.797

0.804

0.886

0.915

0.930

0.931

0.956

0.959

0.963

0.970

0.963

0.954

Positive Predictive Value

0.064

0.088

0.076

0.074

0.092

0.143

0.160

0.245

0.258

0.486

0.539

0.601

0.644

0.600

0.577

False Discovery Rate

0.936

0.912

0.924

0.926

0.908

0.857

0.840

0.755

0.742

0.514

0.461

0.399

0.356

0.400

0.423
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Figure 3.5: Average True Positives, True Negatives, False Positives, False Negatives of highest scoring graphs
with a given number of nodes. Blue line: 25 nodes, Green line: 10 nodes, Purple line: 8 nodes, Red line: 5
nodes.
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Figure 3.6: Average Empty Rows, True Edges, Zero Edges and Significant Edges of highest scoring
graphs with a given number of nodes. Blue line: 25 nodes, Green line: 10 nodes, Purple line: 8 nodes, Red
line: 5 nodes.
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Figure 3.7: Average False Positive Rate, False Negative Rate, True Positive Rate and True Negative Rate
of highest scoring graphs with a given number of nodes. Blue line: 25 nodes, Green line: 10 nodes, Purple
line: 8 nodes, Red line: 5 nodes.
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Figure 3.8: Average Positive Predictive Value and False Discovery Rate of highest scoring graphs with a
given number of nodes. Blue line: 25 nodes, Green line: 10 nodes, Purple line: 8 nodes, Red line: 5 nodes.
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Table 3.6: Average features matrix of graph with 5 nodes
from 5000 data points.
0.000000
0.158010
0.532935
0.036637
0.619317

0.652169
0.000000
0.006691
0.168595
0.652827

0.467065
0.004442
0.000000
0.000000
0.454067

0.054133
0.831405
0.032743
0.000000
0.051116

0.380683
0.347173
0.088850
0.000000
0.000000

Figure 3.9: Graph from features matrix with 5 nodes from
5000 data points. Edges were included where at least 60%
of sampled graphs had an edge.
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Table 3.7: Results of features simulation of graphs with 5 nodes. The highest
scoring graph is shown, as well as the number of graphs within 3 of the
highest scoring graph, and the score the graph with the lowest score within 3
of the highest scoring graph.
Data Points Highest Score
100
-230.569480
-230.569480
-230.569480
-230.569480
-230.569480
300
-230.569480
-230.569480
-230.569480
-230.569480
-230.569480
500
-230.569480
-230.569480
-230.569480
-230.569480
-230.569480
700
-230.569480
-230.569480
-230.569480
-230.569480
-230.569480
900
-230.569480
-230.569480
-230.569480
-230.569480
-230.569480
1500
-230.569480
-230.569480
-230.569480
-230.569480
-230.569480
5000
-230.569480
-230.569480
-230.569480
-230.569480
-230.569480

# of Graphs
3828
3464
3557
3628
3756
3823
3464
3557
3628
3756
3823
3464
3557
3628
3756
3823
3464
3557
3628
3756
3823
3464
3557
3628
3756
3823
3464
3557
3628
3756
3823
3464
3557
3628
3756

Lowest score
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
-233.333649
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Table 3.8: Average features matrix of graph with 8 nodes from 5000 data
points.
0.000000
0.000000
0.067797
0.000000
0.028249
0.531073
0.000000
0.497175

0.000000
0.000000
0.000000
0.000000
1.000000
0.000000
1.000000
1.000000

0.932203
0.000000
0.000000
0.000000
0.548023
0.000000
0.000000
0.000000

0.079096
0.022599
0.101695
0.000000
0.079096
0.073446
0.039548
0.056497

0.000000
0.000000
0.000000
0.016949
0.000000
0.000000
0.000000
0.706215

0.468927
0.000000
0.000000
0.000000
0.000000
0.000000
0.327684
0.000000

0.045198
0.000000
0.000000
0.011299
0.000000
0.576271
0.000000
0.045198

0.502825
0.000000
0.000000
0.000000
0.231638
0.000000
0.000000
0.000000

Figure 3.10: Graph from features matrix with 8 nodes from 5000 data
points. Edges were included where at least 60% of sampled graphs had an
edge.
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Table 3.9: Results of features simulation of graphs with 8 nodes. The highest
scoring graph is shown, as well as the number of graphs within 3 of the
highest scoring graph, and the score the graph with the lowest score within 3
of the highest scoring graph.
Data Points Highest Score
100
-329.228589
-328.403125
-329.871694
-329.505107
-328.403125
300
-328.403125
-328.403125
-329.871694
-329.505107
-328.403125
500
-328.403125
-328.403125
-329.871694
-329.505107
-328.403125
700
-328.403125
-328.403125
-329.871694
-329.505107
-328.403125
900
-328.403125
-328.403125
-329.871694
-329.505107
-328.403125
1500
-328.403125
-328.403125
-329.871694
-329.505107
-328.403125
5000
-328.403125
-328.403125
-329.871694
-329.505107
-328.403125

# of Graphs
57
38
60
25
35
14
38
60
25
35
14
38
60
25
35
14
38
60
25
35
14
38
60
25
35
14
38
60
25
35
14
38
60
25
35

Lowest score
-332.174279
-331.050571
-332.805493
-332.174279
-330.973676
-330.705710
-331.050571
-332.805493
-332.174279
-330.973676
-330.705710
-331.050571
-332.805493
-332.174279
-330.973676
-330.705710
-331.050571
-332.805493
-332.174279
-330.973676
-330.705710
-331.050571
-332.805493
-332.174279
-330.973676
-330.705710
-331.050571
-332.805493
-332.174279
-330.973676
-330.705710
-331.050571
-332.805493
-332.174279
-330.973676
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Table 3.10: Average features matrix of graph with 10 nodes from 5000 data points.
0.000000
0.149758
0.724638
0.101449
0.000000
0.565217
0.000000
0.000000
0.000000
0.719807

0.115942
0.000000
0.004831
0.000000
0.057971
0.000000
0.000000
0.000000
0.024155
0.516908

0.275362
0.135266
0.000000
0.000000
0.096618
0.149758
0.004831
0.000000
0.280193
0.420290

0.898551
0.062802
0.000000
0.000000
0.173913
0.000000
0.000000
0.077295
0.000000
0.000000

0.000000
0.178744
0.164251
0.096618
0.000000
0.164251
0.004831
0.101449
0.019324
0.086957

0.333333
0.000000
0.850242
0.028986
0.000000
0.000000
0.000000
0.000000
0.000000
0.000000

0.000000
0.000000
0.043478
0.000000
0.101449
0.000000
0.000000
0.062802
0.000000
0.019324

0.024155
0.000000
0.159420
0.922705
0.000000
0.178744
0.000000
0.000000
0.033816
0.000000

0.000000
0.294686
0.589372
0.000000
0.053140
0.000000
0.000000
0.000000
0.000000
0.294686

0.028986
0.483092
0.159420
0.000000
0.193237
0.000000
0.009662
0.000000
0.164251
0.000000

Figure 3.11: Graph from features matrix with 10 nodes from 5000 data points. Edges
were included where at least 60% of sampled graphs had an edge.

119
Table 3.11: Results of features simulation of graphs with 10 nodes. The
highest scoring graph is shown, as well as the number of graphs within 3 of
the highest scoring graph, and the score the graph with the lowest score within
3 of the highest scoring graph.
Data Points Highest Score
100
-397.901706
-402.539461
-402.780554
-401.840493
-402.049110
300
-403.001455
-402.539461
-402.780554
-401.840493
-402.049110
500
-403.001455
-402.539461
-402.780554
-401.840493
-402.049110
700
-403.001455
-402.539461
-402.780554
-401.840493
-402.049110
900
-403.001455
-402.539461
-402.780554
-401.840493
-402.049110
1500
-403.001455
-402.539461
-402.780554
-401.840493
-402.049110
5000
-403.001455
-402.539461
-402.780554
-401.840493
-402.049110

# of Graphs
15
35
35
56
11
65
35
35
56
11
65
35
35
56
11
65
35
35
56
11
65
35
35
56
11
65
35
35
56
11
65
35
35
56
11

Lowest score
-400.477969
-405.244542
-405.083139
-404.620754
-404.665614
-405.304041
-405.244542
-405.083139
-404.620754
-404.665614
-405.304041
-405.244542
-405.083139
-404.620754
-404.665614
-405.304041
-405.244542
-405.083139
-404.620754
-404.665614
-405.304041
-405.244542
-405.083139
-404.620754
-404.665614
-405.304041
-405.244542
-405.083139
-404.620754
-404.665614
-405.304041
-405.244542
-405.083139
-404.620754
-404.665614
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displays the original graph on the right (green), and the graph with edges appearing in
60% or more of the sampled graphs on the left (red).
Table 3.12 displays the results of the 5 runs for each level of data points in the features
simulation of a graph with 25 nodes. Increasing the number of data points beyond 300
did not seem to have a positive effect on the highest scoring graph, or the number of
graphs that were within 3 of the highest scoring graph. The seed for each of the 5 runs
was different, although with each number of data points in the simulated data, the same
seeds were used to initialize the random number generator. In Table 3.13, the average
features matrix is created by averaging the number of graphs with any given edge. Table
3.13 was created from the graphs sampled with 5000 data points of simulated data. The
number of graphs used to create the matrix was 36. Figure 3.13 displays the original
graph on the right (green), and the graph with edges appearing in 60% or more of the
sampled graphs on the left (red). This is the only graph presented thus far in the features
simulation where there are false positive edges present.
Shown in Figure 3.12 is the average score of the highest scoring graph in the 5
runs for each level of the four different sized graphs, with the range of data points. It is
obvious that increasing the number of data points above 100, or in one case, 300 does not
improve the average highest score. Figure 3.14 displays bar plots of the four metrics
used to assess the accuracy of the graphs with edges present in 60% or more of the
sampled graphs, made from 5000 data points of simulated data. The graph with 25 nodes
was the only one that had false positives present. False negatives increased with node
size. True negatives increased with node size as well, although true positives did not
increase as much as would be expected.

Figure 3.12: Average highest score of graphs in features simulation. Blue line: 25
nodes, Green line: 10 nodes, Purple line: 8 nodes, Red line: 5 nodes.
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Table 3.12: Results of features simulation of graphs with 25 nodes. The
highest scoring graph is shown, as well as the number of graphs within 3 of
the highest scoring graph, and the score the graph with the lowest score within
3 of the highest scoring graph.
Data Points Highest Score
100
-1289.250427
-1326.141029
-1317.957726
-1264.591519
-1308.418787
300
-1434.744052
-1326.141029
-1317.957726
-1264.591519
-1308.418787
500
-1434.744052
-1326.141029
-1317.957726
-1264.591519
-1308.418787
700
-1434.744052
-1326.141029
-1317.957726
-1264.591519
-1308.418787
900
-1434.744052
-1326.141029
-1317.957726
-1264.591519
-1308.418787
1500
-1434.744052
-1326.141029
-1317.957726
-1264.591519
-1308.418787
5000
-1434.744052
-1326.141029
-1317.957726
-1264.591519
-1308.418787

# of Graphs
29
2
3
1
3
22
2
3
1
3
22
2
3
1
3
22
2
3
1
3
22
2
3
1
3
22
2
3
1
3
22
2
3
1
3

Lowest score
-1291.752328
-1326.924291
-1317.957726
-1264.591519
-1308.418787
-1437.035017
-1326.924291
-1317.957726
-1264.591519
-1308.418787
-1437.035017
-1326.924291
-1317.957726
-1264.591519
-1308.418787
-1437.035017
-1326.924291
-1317.957726
-1264.591519
-1308.418787
-1437.035017
-1326.924291
-1317.957726
-1264.591519
-1308.418787
-1437.035017
-1326.924291
-1317.957726
-1264.591519
-1308.418787
-1437.035017
-1326.924291
-1317.957726
-1264.591519
-1308.418787
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Table 3.13: Average features matrix of graph with 25 nodes from 5000 data points.
0.000

0.111

0.111

0.111

0.111

0.639

0.000

0.889

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.083

0.056

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.111

0.000

0.000

0.111

0.000

0.000

0.000

0.111

0.000

0.056

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.111

0.000

0.000

0.167

0.000

0.639

0.000

0.000

0.000

0.000

0.000

0.000

0.639

0.000

0.000

0.111

0.028

0.000

0.083

0.000

0.000

0.361

0.000

0.000

0.000

0.000

0.000

0.000

0.250

0.056

0.000

0.000

0.000

0.639

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.194

0.000

0.111

0.000

0.000

0.000

0.000

0.000

0.056

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.083

0.250

0.000

0.000

0.000

0.000

0.639

0.083

0.083

0.000

0.000

0.000

0.750

0.000

0.000

0.083

0.556

0.000

0.000

0.167

0.083

0.000

0.000

0.639

0.000

0.000

0.000

0.000

0.000

0.694

0.000

0.000

0.000

0.000

0.694

0.000

0.000

0.750

0.000

0.000

0.194

0.000

0.000

0.000

0.000

0.000

0.167

0.750

0.806

0.000

0.111

0.000

0.000

0.194

0.194

0.556

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.806

0.111

0.000

0.000

0.083

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.194

0.000

0.000

0.611

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.361

0.000

0.000

0.000

0.111

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.194

0.000

0.111

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.111

0.000

0.667

0.000

0.111

0.000

0.306

0.000

0.000

0.639

0.111

0.194

0.639

0.111

0.000

0.111

0.000

0.639

0.833

0.111

0.667

0.000

0.000

0.083

0.000

0.722

0.722

0.111

0.111

0.806

0.639

0.111

0.000

0.694

0.083

0.083

0.722

0.111

0.000

0.750

0.000

0.194

0.000

0.556

0.722

0.083

0.000

0.639

0.000

0.111

0.750

0.639

0.111

0.167

0.000

0.000

0.000

0.639

0.000

0.250

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.250

0.000

0.000

0.000

0.000

0.000

0.056

0.000

0.111

0.000

0.139

0.000

0.000

0.750

0.000

0.000

0.000

0.000

0.000

0.000

0.278

0.000

0.000

0.000

0.639

0.000

0.639

0.000

0.000

0.000

0.056

0.111

0.000

0.000

0.111

0.000

0.056

0.083

0.000

0.194

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.639

0.722

0.250

0.056

0.000

0.000

0.000

0.611

0.111

0.000

0.000

0.056

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.167

0.000

0.056

0.000

0.000

0.250

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.083

0.000

0.111

0.000

0.000
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Figure 3.13: Graph from features matrix with 25 nodes from 5000 data points. Edges were included where at least 60% of
sampled graphs had an edge.
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Figure 3.14: Scoring metrics of features graph with 5,000 data points. Blue line
(Bar 4): 25 nodes, Green line (Bar 3): 10 nodes, Purple line (Bar 2): 8 nodes, Red
line (Bar 1): 5 nodes.
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V. Discussion
Two different simulations were completed in this chapter, which attempted to
assess the accuracy of a sampling algorithm for learning the structure of a Bayesian
Network. The first simulation tested the accuracy of learning the overall topological
structure of a graph. Graphs of 5, 8, 10 and 25 nodes were tested, using an increasing
amount of simulated data. One important problem in applying such methods to real
biological data is that too much data is required to accurately learn the graph structure.
This was tested by using graphs with known structures, and simulating data to represent
them. Several different metrics were used to determine the accuracy of the learned graph
versus the original graph. In the graph with 5 nodes, increasing the amount of data used
to learn the graph seemed to have a positive effect on the learned graphs. The average
number of true positives increased with the amount of data, although the number of true
negatives did not seem to be affected. False positives actually increased slightly, while
false negatives decreased, as was expected. Additionally, the number of empty rows
present in the conditional probability tables decreased down to zero, proving that 5000
data points was a sufficient amount of data to learn the model. The same basic trends
were seen in the graph with 8 nodes, with the exception that false positives decreased
slightly, instead of increasing. Also there were still empty rows in the conditional
probability tables, even with 5000 data points, which indicates that this is not enough data
to learn the model. The graph with 10 nodes displayed the expected trends, where
increasing the amount of data caused an increase in the number of true positives and true
negatives, while decreasing the number of false negatives and false positives. The
number of empty conditional probability tables decreased while the amount of data
increased, although there was still an average of 3 empty rows, even with 5000 data
points, which again indicates this is not a sufficient amount of data. When a graph with
25 nodes was tested, these same basic trends were observed, however there was a definite
increase in the number of false positives and false negatives. Even with 5000 data points
used, there was still an average of 27 false positives and 15 false negatives. This was a
dramatic increase over these numbers in a graph of 10 nodes. Additionally, there was an
average of more than 25 empty rows in the conditional probability tables with 5000 data
points, again indicating a lack of sufficient data. With each of these four different sizes
of graphs, the positive predictive value had an overall increase with the number of data
points, while the false discovery rate had an overall decrease, although these were not
perfect linear trends.
While it is important to consider the overall topological structure of a graph, as
was done in the first simulation, it is also of interest to be able to identify nodes that are
densely connected in the graph (i.e. have a high degree). This is particularly true in the
application of such methods to the biological domain, as genes in a graph with a high
degree would be of particular interest to test experimentally in knockout studies. Because
of this, a second simulation was performed, which aimed to identify edges that are
present in the majority of high-scoring graphs. This was tested in the same way as
before, using four graphs of 5, 8, 10 and 25 nodes each, while supplying an increasing
amount of data. Ten thousand graphs were sampled five times with each number of data
points, and a different seed being used each time to initialize the random number
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generator. Interestingly, it was found that increasing the amount of data beyond 300
points did not increase the highest scoring graph’s score, nor did it increase the number of
graphs that had a score within 3 of the highest scoring one. Since there were 10,000
graphs sampled in each iteration of the simulation, and 5 replicates, for every number of
data points used for each size of graph, there were a total of 50,000 graphs sampled.
Edges that were present in 60% of more of these 50,000 graphs were kept in a “features
matrix”, which is essentially an incidence matrix that contains percentages instead of a
binary digit to indicate the presence or absence of an edge. From these matrices, graphs
were built and visualized in ALIVE, to compare the original and learned graphs. While
many edges were missing in the learned graphs, there were also many features that were
correctly identified. No false positives were observed until the graph with 25 nodes was
tested, in which there were more than 40 false positive edges present. The number of
false negative edges in the learned graphs increased with node size, as did the number of
true negative edges. The most important measure though, was the number of true
positives. This had little increase between the graphs of 5, 8 and 10 nodes, although there
was a dramatic increase in this number in the graph containing 25 nodes.
Overall, these results show that it might be possible to build Bayesian Networks
from real biological data. While no model learned from the data could be considered to
be exact, it could potentially identify the nodes in the graph with the highest degree (the
hubs), which are of great interest in further biological dissection. It would be expected
that many extraneous parts of the graph would be missed or incorrectly identified,
however these are most likely of lesser biological importance anyways. The results
above show though that using as few as 300 microarrays, a fairly accurate network could
be learned from the data.
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